{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:28:25Z","timestamp":1792783705105,"version":"4.5.0"},"reference-count":390,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Russian Scientific Foundation","award":["16-14-00083"],"award-info":[{"award-number":["16-14-00083"]}]},{"DOI":"10.13039\/501100003443","name":"Ministry of Education and Science of the Russian Federation","doi-asserted-by":"crossref","award":["0309-2016-0002"],"award-info":[{"award-number":["0309-2016-0002"]}],"id":[{"id":"10.13039\/501100003443","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003243","name":"Ministry of Health of the Czech Republic","doi-asserted-by":"crossref","award":["16-34238A"],"award-info":[{"award-number":["16-34238A"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"crossref"}]},{"name":"FIT","award":["CZ.02.1.01\/0.0\/0.0\/15_003\/0000495"],"award-info":[{"award-number":["CZ.02.1.01\/0.0\/0.0\/15_003\/0000495"]}]},{"name":"European Regional Development"},{"name":"MIMS"},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"crossref","award":["2017-02438"],"award-info":[{"award-number":["2017-02438"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001729","name":"Swedish Foundation for Strategic Research","doi-asserted-by":"crossref","award":["FFL12-0089"],"award-info":[{"award-number":["FFL12-0089"]}],"id":[{"id":"10.13039\/501100001729","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Ministry of Higher Education, Science and Sport of Slovenia","award":["P3-0083"],"award-info":[{"award-number":["P3-0083"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.antiviral.2019.01.014","type":"journal-article","created":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T23:11:43Z","timestamp":1548889903000},"page":"23-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":420,"special_numbering":"C","title":["Tick-borne encephalitis in Europe and Russia: Review of pathogenesis, clinical features, therapy, and vaccines"],"prefix":"10.1016","volume":"164","author":[{"given":"Daniel","family":"Ruzek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatjana","family":"Av\u0161i\u010d \u017dupanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Borde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4572-745X","authenticated-orcid":false,"given":"Ales","family":"Chrdle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludek","family":"Eyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galina","family":"Karganova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Kholodilov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nata\u0161a","family":"Knap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liubov","family":"Kozlovskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey","family":"Matveev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0462-2945","authenticated-orcid":false,"given":"Dmitry I.","family":"Osolodkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6553-0940","authenticated-orcid":false,"given":"Anna K.","family":"\u00d6verby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Tikunova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey","family":"Tkachev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5695-1652","authenticated-orcid":false,"given":"Joanna","family":"Zajkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.antiviral.2019.01.014_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0140545","article-title":"Human CD4+ T Helper Cell Responses after Tick-Borne Encephalitis Vaccination and Infection","volume":"10","author":"Aberle","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.antiviral.2019.01.014_bib2","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/tav020","article-title":"Analysis of delayed TBE-vaccine booster after primary vaccination","volume":"23","author":"Aerssens","year":"2016","journal-title":"J. Trav. Med."},{"issue":"78","key":"10.1016\/j.antiviral.2019.01.014_bib3","first-page":"88","article-title":"Experimental studies cross immune response to antigens of the virus strains of tick-borne encephalitis different genotypes in BALB\/c mice, immunized with various embodiments of tick-borne encephalitis vaccine","volume":"5","author":"Afonina","year":"2014","journal-title":"Epidemiology and Vaccinal prevention"},{"issue":"5","key":"10.1016\/j.antiviral.2019.01.014_bib4","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.4161\/hv.23802","article-title":"Epidemiology of tick-borne encephalitis (TBE) in Europe and its prevention by available vaccines","volume":"9","author":"Amicizia","year":"2013","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.antiviral.2019.01.014_bib5","series-title":"Tick-borne Encephalitis","author":"Ammosov","year":"2006"},{"issue":"16","key":"10.1016\/j.antiviral.2019.01.014_bib6","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1016\/j.vaccine.2010.02.001","article-title":"Vaccine failures after active immunisation against tick-borne encephalitis","volume":"28","author":"Andersson","year":"2010","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.antiviral.2019.01.014_bib7","first-page":"428","article-title":"The variability of tick-borne encephalitis virus. 7. Reactogenic and immunogenic properties of attenuated strain I-40 D upon oral vaccination of volunteers","volume":"15","author":"Andzhaparidze","year":"1970","journal-title":"Vopr. Virusol."},{"key":"10.1016\/j.antiviral.2019.01.014_bib8","first-page":"147","article-title":"The administration of formalin-inactivated RSSE virus vaccine in the Kyasanur Forest disease area of Shimoga District, Mysore State","volume":"50","author":"Aniker","year":"1962","journal-title":"Indian J. Med. Res."},{"issue":"51","key":"10.1016\/j.antiviral.2019.01.014_bib9","first-page":"64","article-title":"Results of a clinical immunogenicity and safety trial of Tick-E-Vac 0.25 ml vaccine (pediatric dosage)","volume":"5","author":"Ankudinova","year":"2014","journal-title":"Vestnik uralskoi meditsinskoi akademicheskoi nauki"},{"key":"10.1016\/j.antiviral.2019.01.014_bib10","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ejmech.2017.06.014","article-title":"Perylenyltriazoles inhibit reproduction of enveloped viruses","volume":"138","author":"Aralov","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"9011","key":"10.1016\/j.antiviral.2019.01.014_bib11","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/S0140-6736(96)90977-0","article-title":"Do specific hyperimmunoglobulins aggravate clinical course of tick-borne encephalitis?","volume":"347","author":"Arras","year":"1996","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.antiviral.2019.01.014_bib12","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.vaccine.2011.11.061","article-title":"Immunogenicity of delayed TBE-vaccine booster","volume":"30","author":"Askling","year":"2012","journal-title":"Vaccine"},{"issue":"Pt 2","key":"10.1016\/j.antiviral.2019.01.014_bib13","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1099\/vir.0.043984-0","article-title":"Toll-like receptor 7 suppresses virus replication in neurons but does not affect viral pathogenesis in a mouse model of Langat virus infection","volume":"94","author":"Baker","year":"2013","journal-title":"J. Gen. Virol."},{"issue":"12","key":"10.1016\/j.antiviral.2019.01.014_bib14","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/657418","article-title":"Variability in the 2'-5'-oligoadenylate synthetase gene cluster is associated with human predisposition to tick-borne encephalitis virus-induced disease","volume":"202","author":"Barkhash","year":"2010","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.antiviral.2019.01.014_bib15","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.antiviral.2011.10.017","article-title":"Single nucleotide polymorphism in the promoter region of the CD209 gene is associated with human predisposition to severe forms of tick-borne encephalitis","volume":"93","author":"Barkhash","year":"2012","journal-title":"Antivir. Res."},{"issue":"2","key":"10.1016\/j.antiviral.2019.01.014_bib16","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.antiviral.2013.05.008","article-title":"Association of single nucleotide polymorphism rs3775291 in the coding region of the TLR3 gene with predisposition to tick-borne encephalitis in a Russian population","volume":"99","author":"Barkhash","year":"2013","journal-title":"Antivir. Res."},{"issue":"5","key":"10.1016\/j.antiviral.2019.01.014_bib17","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.ttbdis.2016.03.019","article-title":"Association of IL28B and IL10 gene polymorphism with predisposition to tick-borne encephalitis in a Russian population","volume":"7","author":"Barkhash","year":"2016","journal-title":"Ticks Tick Borne Dis"},{"issue":"4","key":"10.1016\/j.antiviral.2019.01.014_bib18","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.ttbdis.2018.02.010","article-title":"A matrix metalloproteinase 9 (MMP9) gene single nucleotide polymorphism is associated with predisposition to tick-borne encephalitis virus-induced severe central nervous system disease","volume":"9","author":"Barkhash","year":"2018","journal-title":"Ticks Tick Borne Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.antiviral.2019.01.014_bib19","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/S0264-410X(02)00814-9","article-title":"History of TBE vaccines","volume":"21","author":"Barrett","year":"2003","journal-title":"Vaccine"},{"issue":"29","key":"10.1016\/j.antiviral.2019.01.014_bib20","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1016\/j.vaccine.2014.05.012","article-title":"A protective chimeric antibody to tick-borne encephalitis virus","volume":"32","author":"Baykov","year":"2014","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.antiviral.2019.01.014_bib21","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1136\/jnnp.2004.040469","article-title":"Severe tick borne encephalitis with simultaneous brain stem, bithalamic, and spinal cord involvement documented by MRI","volume":"76","author":"Bender","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"34","key":"10.1016\/j.antiviral.2019.01.014_bib22","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1016\/j.vaccine.2014.06.028","article-title":"Five year follow-up after a first booster vaccination against tick-borne encephalitis following different primary vaccination schedules demonstrates long-term antibody persistence and safety","volume":"32","author":"Beran","year":"2014","journal-title":"Vaccine"},{"issue":"20","key":"10.1016\/j.antiviral.2019.01.014_bib23","doi-asserted-by":"crossref","first-page":"12828","DOI":"10.1128\/JVI.79.20.12828-12839.2005","article-title":"Inhibition of interferon-stimulated JAK-STAT signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonist","volume":"79","author":"Best","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.01.014_bib24","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.antiviral.2014.04.006","article-title":"Arbidol as a broad-spectrum antiviral: an update","volume":"107","author":"Blaising","year":"2014","journal-title":"Antivir. Res."},{"issue":"7","key":"10.1016\/j.antiviral.2019.01.014_bib25","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.4049\/jimmunol.1600950","article-title":"NK cell responses to human tick-borne encephalitis virus infection","volume":"197","author":"Blom","year":"2016","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.antiviral.2019.01.014_bib26","doi-asserted-by":"crossref","first-page":"430","DOI":"10.12998\/wjcc.v3.i5.430","article-title":"Tick-borne encephalitis: a review of epidemiology, clinical characteristics, and management","volume":"3","author":"Bogovic","year":"2015","journal-title":"World Journal of Clinical Cases\u202f: WJCC."},{"issue":"4","key":"10.1016\/j.antiviral.2019.01.014_bib27","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.tmaid.2010.05.011","article-title":"What tick-borne encephalitis may look like: clinical signs and symptoms","volume":"8","author":"Bogovic","year":"2010","journal-title":"Trav. Med. Infect. Dis."},{"issue":"2","key":"10.1016\/j.antiviral.2019.01.014_bib28","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ttbdis.2017.12.001","article-title":"The long-term outcome of tick-borne encephalitis in Central Europe","volume":"9","author":"Bogovi\u010d","year":"2018","journal-title":"Ticks Tick Borne Dis"},{"key":"10.1016\/j.antiviral.2019.01.014_bib29","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/nrd.2017.33","article-title":"Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond","volume":"16","author":"Boldescu","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.antiviral.2019.01.014_bib30","series-title":"Dobler G.TBE .Chapter TBE in Adults","first-page":"1","article-title":"Tick-borne encephalitis in adults","author":"Borde","year":"2017"},{"key":"10.1016\/j.antiviral.2019.01.014_bib31","first-page":"30","article-title":"Epidemiological efficacy of the vaccination against tick-borne encephalitis in the Krasnoyarsky krai","volume":"2","author":"Borodina","year":"2004","journal-title":"Biopreparations"},{"issue":"12","key":"10.1016\/j.antiviral.2019.01.014_bib32","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1002\/lt.20594","article-title":"High dose intravenous immunoglobulin treatment: mechanisms of action","volume":"11","author":"Boros","year":"2005","journal-title":"Liver Transplant."},{"issue":"9","key":"10.1016\/j.antiviral.2019.01.014_bib33","doi-asserted-by":"crossref","first-page":"869","DOI":"10.2340\/16501977-1849","article-title":"How flexible is coping after acquired brain injury? A 1-year prospective study investigating coping patterns and influence of self-efficacy, executive functioning and self-awareness","volume":"46","author":"Brands","year":"2014","journal-title":"J. Rehabil. Med."},{"issue":"7","key":"10.1016\/j.antiviral.2019.01.014_bib34","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.vaccine.2007.11.046","article-title":"After a tick bite in a tick-borne encephalitis virusendemic area: current positions about post-exposure treatment","volume":"26","author":"Br\u00f6ker","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2019.01.014_bib35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12028-012-9695-z","article-title":"Guidelines for the evaluation and management of status epilepticus","volume":"17","author":"Brophy","year":"2012","journal-title":"Neurocrit Care"},{"issue":"12","key":"10.1016\/j.antiviral.2019.01.014_bib36","doi-asserted-by":"crossref","DOI":"10.2807\/ese.17.12.20128-en","article-title":"Tick-borne encephalitis transmitted by unpasteurised cow milk in western Hungary, September to October 2011","volume":"17","author":"Caini","year":"2012","journal-title":"Euro Surveill."},{"issue":"Pt 1","key":"10.1016\/j.antiviral.2019.01.014_bib37","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1099\/0022-1317-70-1-37","article-title":"Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera","volume":"70","author":"Calisher","year":"1989","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2019.01.014_bib38","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/S0140-6736(67)90946-4","article-title":"Corticosteroid in aseptic meningitis","volume":"23","author":"Cantu","year":"1967","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2019.01.014_bib39","doi-asserted-by":"crossref","first-page":"11979","DOI":"10.1074\/jbc.M210914200","article-title":"Inhibition of hepatitis C virus RNA replication by 2 '-modified nucleoside analogs","volume":"278","author":"Carroll","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2019.01.014_bib40","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1128\/AAC.01152-10","article-title":"Antiviral efficacy upon administration of a HepDirect prodrug of 2 '-C-methylcytidine to hepatitis C virus-infected chimpanzees","volume":"55","author":"Carroll","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.antiviral.2019.01.014_bib41","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1084\/jem.79.1.45","article-title":"Relationship of the virus of Louping ill in sheep and the virus of Russian spring-summer encephalitis in man","volume":"79","author":"Casals","year":"1944","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.antiviral.2019.01.014_bib42","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0065-3527(03)60008-4","article-title":"Pathogenesis of flavivirus encephalitis","volume":"60","author":"Chambers","year":"2003","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.antiviral.2019.01.014_bib43","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1128\/AAC.00140-10","article-title":"Inhibition of dengue virus RNA synthesis by an adenosine nucleoside","volume":"54","author":"Chen","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2019.01.014_bib44","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.antiviral.2015.07.010","article-title":"The search for nucleoside\/nucleotide analog inhibitors of dengue virus","volume":"122","author":"Chen","year":"2015","journal-title":"Antivir. Res."},{"issue":"20","key":"10.1016\/j.antiviral.2019.01.014_bib45","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1016\/j.vaccine.2016.03.041","article-title":"Protective immunity spectrum induced by immunization with a vaccine from the TBEV strain Sofjin","volume":"34","author":"Chernokhaeva","year":"2016","journal-title":"Vaccine"},{"issue":"13","key":"10.1016\/j.antiviral.2019.01.014_bib46","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.7150\/ijms.21875","article-title":"Peptides as therapeutic agents for dengue virus","volume":"14","author":"Chew","year":"2017","journal-title":"Int. J. Med. Sci."},{"issue":"2","key":"10.1016\/j.antiviral.2019.01.014_bib47","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/1348-0421.12122","article-title":"Evaluation of the European tick-borne encephalitis vaccine against Omsk hemorrhagic fever virus","volume":"58","author":"Chidumayo","year":"2014","journal-title":"Microbiol. Immunol."},{"issue":"26","key":"10.1016\/j.antiviral.2019.01.014_bib48","doi-asserted-by":"crossref","first-page":"15125","DOI":"10.1073\/pnas.011593298","article-title":"Viperin (cig5), an IFN-inducible antiviral protein directly induced by human cytomegalovirus","volume":"98","author":"Chin","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2019.01.014_bib49","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0934-8840(99)80012-7","article-title":"Clinical picture of TBE; a retrospective study of 493 cases","volume":"289","author":"Chmelik","year":"1999","journal-title":"Zentbl. Bakteriol."},{"key":"10.1016\/j.antiviral.2019.01.014_bib50","first-page":"397","volume":"vol. 10","author":"Chmelik","year":"2004"},{"issue":"2","key":"10.1016\/j.antiviral.2019.01.014_bib51","first-page":"65","article-title":"Study of ultraviral encephalitis. Message 3. Kozhevnikov epilepsy and tick-borne encephalitis","volume":"13","author":"Chumakov","year":"1944","journal-title":"J. of neuropathology and psychiatry"},{"key":"10.1016\/j.antiviral.2019.01.014_bib52","first-page":"415","article-title":"Experience in the experimental production and control of tissue culture vaccine against tick encephalitis","volume":"29","author":"Chumakov","year":"1963","journal-title":"Vopr. Virusol."},{"key":"10.1016\/j.antiviral.2019.01.014_bib53","first-page":"307","article-title":"Comparative study of the epidemiological effectiveness of vaccination with tissue-culture and brain vaccine against tick encephalitis","volume":"22","author":"Chumakov","year":"1963","journal-title":"Vopr. Virusol."},{"issue":"3","key":"10.1016\/j.antiviral.2019.01.014_bib54","first-page":"266","article-title":"Effect of the duration of intervals between vaccinations on the effectiveness of vaccination and revaccination against tick-borne encephalitis","volume":"10","author":"Chumakov","year":"1965","journal-title":"Vopr. Virusol."},{"issue":"2","key":"10.1016\/j.antiviral.2019.01.014_bib55","first-page":"168","article-title":"Studies on factors influencing the effectiveness of immunization against tick-borne encephalitis. I. Effect of immunogenic properties of vaccines on the effectiveness of vaccination and revaccination","volume":"10","author":"Chumakov","year":"1965","journal-title":"Vopr. Virusol."},{"issue":"Suppl. 1","key":"10.1016\/j.antiviral.2019.01.014_bib56","first-page":"161","article-title":"New perspective vaccines from tick-borne encephalitis virus propagated in green monkey kidney cell cultures","author":"Chumakov","year":"1990","journal-title":"Arch. Virol."},{"issue":"1","key":"10.1016\/j.antiviral.2019.01.014_bib57","first-page":"36","article-title":"A new prospective vaccine against tick-borne encephalitis","author":"Chumakov","year":"1991","journal-title":"Zh. Mikrobiol. Epidemiol. Immunobiol."},{"issue":"8","key":"10.1016\/j.antiviral.2019.01.014_bib58","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s00134-013-2938-4","article-title":"Neurointensive Care Section of the European Society of Intensive Care Medicine. Recommendations on the use of EEG monitoring in critically ill patients: consensus statement from the neurointensive care section of the ESICM","volume":"39","author":"Claassen","year":"2013","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.antiviral.2019.01.014_bib59","first-page":"45","article-title":"Studies on antigenic relationships among the viruses of the group B tick-borne complex","volume":"31","author":"Clarke","year":"1964","journal-title":"Bull. World Health Organ."},{"issue":"7","key":"10.1016\/j.antiviral.2019.01.014_bib60","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1128\/JVI.02882-12","article-title":"5-(Perylen-3-yl)ethynyl-arabino-uridine (aUY11), an arabino-based rigid amphipathic fusion inhibitor, targets virion envelope lipids to inhibit fusion of influenza virus, hepatitis C virus, and other enveloped viruses","volume":"87","author":"Colpitts","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.01.014_bib61","doi-asserted-by":"crossref","first-page":"6895","DOI":"10.1073\/pnas.111085598","article-title":"RNA virus error catastrophe: direct molecular test by using ribavirin","volume":"98","author":"Crotty","year":"2001","journal-title":"P Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.antiviral.2019.01.014_bib62","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ttbdis.2013.11.005","article-title":"Evaluation of hyponatraemia in patients with tick-borne encephalitis--a preliminary study","volume":"5","author":"Czupryna","year":"2014","journal-title":"Ticks Tick Borne Dis"},{"issue":"1","key":"10.1016\/j.antiviral.2019.01.014_bib63","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41426-018-0081-6","article-title":"A new subtype of eastern tick-borne encephalitis virus discovered in Qinghai-Tibet Plateau, China","volume":"7","author":"Dai","year":"2018","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.antiviral.2019.01.014_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-pharmtox-010510-100228","article-title":"A 40-year journey in search of selective antiviral chemotherapy","volume":"51","author":"De Clercq","year":"2011","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.antiviral.2019.01.014_bib65","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1021\/acs.jmedchem.5b01157","article-title":"C-nucleosides to Be revisited","volume":"59","author":"De Clercq","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2019.01.014_bib66","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/978-3-540-79086-0_3","article-title":"Antiviral agents acting as DNA or RNA chain terminators","volume":"189","author":"De Clercq","year":"2009","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.antiviral.2019.01.014_bib67","article-title":"Vaccines for preventing tick-borne encephalitis","volume":"1","author":"Demicheli","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"issue":"6","key":"10.1016\/j.antiviral.2019.01.014_bib68","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/jmv.21765","article-title":"Genotyping and characterization of the geographical distribution of tick-borne encephalitis virus variants with a set of molecular probes","volume":"82","author":"Demina","year":"2010","journal-title":"J. Med. Virol."},{"issue":"10","key":"10.1016\/j.antiviral.2019.01.014_bib69","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.4161\/hv.29984","article-title":"Immunogenicity against Far Eastern and Siberian subtypes of tick-borne encephalitis (TBE) virus elicited by the currently available vaccines based on the European subtype: systematic review and meta-analysis","volume":"10","author":"Domnich","year":"2014","journal-title":"Hum. Vaccines Immunother."},{"issue":"7","key":"10.1016\/j.antiviral.2019.01.014_bib70","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/jmv.24759","article-title":"The phenomenon of released\u2010activity. Reply on comment on Don et al.: dose\u2010dependent antiviral activity of released\u2010active form of antibodies to interferon\u2010gamma against influenza A\/California\/07\/09(H1N1) in murine model","volume":"89","author":"Don","year":"2017","journal-title":"J. Med. Virol."},{"issue":"1","key":"10.1016\/j.antiviral.2019.01.014_bib71","first-page":"27","article-title":"Meta-analysis of post-registration monitoring of Jodantipyrin\u00ae for emergency prevention of tick-borne encephalitis in endemic areas of Russia","author":"Doroshenko","year":"2013","journal-title":"Terra Medica"},{"issue":"4","key":"10.1016\/j.antiviral.2019.01.014_bib72","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.tmaid.2010.05.010","article-title":"Tick-borne encephalitis virus and the immune response of the mammalian host","volume":"8","author":"D\u00f6rrbecker","year":"2010","journal-title":"Trav. Med. Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.01.014_bib73","first-page":"16","article-title":"Main biological properties of the vaccine strain Elantsev of tick-borne encephalitis virus. Life vaccine against tick-borne encephalitis","volume":"3","author":"Doubov","year":"1969","journal-title":"Proceedings of Tyumen SRI of infectious pathology"},{"key":"10.1016\/j.antiviral.2019.01.014_bib74","first-page":"11","article-title":"Results of life vaccine against tick-borne encephalitis elaborated epidemiological trials","volume":"4","author":"Doubov","year":"1971","journal-title":"Proceedings of Tyumen SRI of infectious pathology"},{"key":"10.1016\/j.antiviral.2019.01.014_bib75","series-title":"[Molecular Design of Fusion Inhibitors for Tick-borne Flaviviruses]","author":"Dueva","year":"2016"},{"key":"10.1016\/j.antiviral.2019.01.014_bib76","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/jmv.24761","article-title":"Homeopathy in disguise. Comment on Don et al.: dose-dependent antiviral activity of released-active form of antibodies to interferon-gamma against influenza A\/California\/07\/09(H1N1) in murine model","volume":"89","author":"Dueva","year":"2017","journal-title":"J. Med. Virol."},{"issue":"10","key":"10.1016\/j.antiviral.2019.01.014_bib77","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/minf.201300185","article-title":"Interaction of flaviviruses with reproduction inhibitors binding in \u03b2-OG pocket: insights from molecular dynamics simulations","volume":"33","author":"Dueva","year":"2014","journal-title":"Mol Inf"},{"issue":"32","key":"10.1016\/j.antiviral.2019.01.014_bib78","first-page":"984","article-title":"Corticoids in the therapy of TBE and other viral encephalitides","volume":"113","author":"Duniewicz","year":"1974","journal-title":"Cas. Lek. Cesk."},{"issue":"4","key":"10.1016\/j.antiviral.2019.01.014_bib79","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/BF01642770","article-title":"[Central European tick-borne encephalitis from 1969 to 1972 in central bohemia (Czech)]","volume":"3","author":"Duniewicz","year":"1975","journal-title":"Infection"},{"key":"10.1016\/j.antiviral.2019.01.014_bib80","series-title":"Epidemiological Situation of Tick-borne Encephalitis in the European Union and Europe Free Trade Association Countries. ECDC Technical Report","year":"2012"},{"issue":"Pt 1","key":"10.1016\/j.antiviral.2019.01.014_bib81","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1099\/0022-1317-80-1-179","article-title":"Sequence analysis and genetic classification of tick-borne encephalitis viruses from Europe and Asia","volume":"80","author":"Ecker","year":"1999","journal-title":"J. Gen. Virol."},{"issue":"2","key":"10.1016\/j.antiviral.2019.01.014_bib82","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0264-410X(03)00563-2","article-title":"Randomized, phase II dose-finding studies of a modified tick-borne encephalitis vaccine: evaluation of safety and immunogenicity","volume":"22","author":"Ehrlich","year":"2003","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.antiviral.2019.01.014_bib83","first-page":"341","article-title":"Concentrated purified vaccine against tick-borne encephalitis prepared by means of zonal ultracentrifugation. Development of the preparation","author":"El'bert","year":"1980","journal-title":"Vopr. Virusol."},{"issue":"1","key":"10.1016\/j.antiviral.2019.01.014_bib84","first-page":"56","article-title":"Donor immunization with an inactivated concentrated purified vaccine against tick-borne encephalitis to obtain immune blood preparations","volume":"29","author":"El'bert","year":"1984","journal-title":"Vopr. Virusol."},{"issue":"1","key":"10.1016\/j.antiviral.2019.01.014_bib85","first-page":"90","article-title":"Concentrated and purified vaccine against tick-borne encephalitis prepared by ultracentrifugation and chromatography","volume":"30","author":"El'bert","year":"1985","journal-title":"Vopr. Virusol."},{"issue":"3","key":"10.1016\/j.antiviral.2019.01.014_bib86","first-page":"219","article-title":"The purification of tick-borne encephalitis virus preparations of cellular DNA","volume":"35","author":"El'bert","year":"1990","journal-title":"Vopr. Virusol."},{"issue":"5","key":"10.1016\/j.antiviral.2019.01.014_bib87","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/0264-410X(89)90183-7","article-title":"Inactivated vaccine against tick-borne encephalitis (TBE) derived from heteroploid continuous monkey cell line","volume":"7","author":"Elbert","year":"1989","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2019.01.014_bib88","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1021\/jm030424e","article-title":"Structure-activity relationship of purine ribonucleosides for inhibition of hepatitis C virus RNA-dependent RNA polymerase","volume":"47","author":"Eldrup","year":"2004","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.antiviral.2019.01.014_bib89","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ttbdis.2016.11.007","article-title":"Tick-borne encephalitis vorus neutralization by high dose intravenous immunoglobulin","volume":"8","author":"Elsterova","year":"2017","journal-title":"Ticks Tick Borne Dis"},{"key":"10.1016\/j.antiviral.2019.01.014_bib90","first-page":"274","article-title":"Epidemiology by country","volume":"vol. 114","author":"Erber","year":"2018"},{"issue":"1","key":"10.1016\/j.antiviral.2019.01.014_bib91","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1089\/vbz.2015.1896","article-title":"A review of methods for detecting tick-borne encephalitis virus infection in tick, animal, and human specimens","volume":"16","author":"Ergunay","year":"2016","journal-title":"Vector Borne Zoonotic Dis."},{"key":"10.1016\/j.antiviral.2019.01.014_bib92","first-page":"229","article-title":"Immunobiological characteristics of tick-borne encephalitis vaccine, prepared from attenuated virus","volume":"vol. 26","author":"Erofeev","year":"1976"},{"issue":"9","key":"10.1016\/j.antiviral.2019.01.014_bib93","doi-asserted-by":"crossref","first-page":"5483","DOI":"10.1128\/AAC.00807-15","article-title":"Nucleoside inhibitors of tick-borne encephalitis virus","volume":"59","author":"Eyer","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2019.01.014_bib94","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.antiviral.2016.07.018","article-title":"Structure-activity relationships of nucleoside analogues for inhibition of tick-borne encephalitis virus","volume":"133","author":"Eyer","year":"2016","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.01.014_bib95","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.antiviral.2017.03.012","article-title":"Antiviral activity of the adenosine analogue BCX4430 against West Nile virus and tick-borne flaviviruses","volume":"142","author":"Eyer","year":"2017","journal-title":"Antivir. Res."},{"issue":"21","key":"10.1016\/j.antiviral.2019.01.014_bib96","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01028-17","article-title":"Escape of tick-borne flavivirus from 2'-C-methylated nucleoside antivirals is mediated by a single conservative mutation in NS5 that has a dramatic effect on viral fitness","volume":"91","author":"Eyer","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.01.014_bib97","doi-asserted-by":"crossref","DOI":"10.1177\/2040206618761299","article-title":"Nucleoside analogs as a rich source of antiviral agents active against arthropod-borne flaviviruses","volume":"26","author":"Eyer","year":"2018","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.antiviral.2019.01.014_bib98","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.virusres.2016.04.021","article-title":"Antiviral activity of luteolin against Japanese encephalitis virus","volume":"220","author":"Fan","year":"2016","journal-title":"Virus Res."},{"issue":"7","key":"10.1016\/j.antiviral.2019.01.014_bib99","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.micinf.2010.03.015","article-title":"Ixodes ricinus tick saliva modulates tick-borne encephalitis virus infection of dendritic cells","volume":"12","author":"Fialov\u00e1","year":"2010","journal-title":"Microb. Infect."},{"key":"10.1016\/j.antiviral.2019.01.014_bib100","doi-asserted-by":"crossref","DOI":"10.1007\/s10072-016-2724-5","article-title":"Improvement rate of patients with severe brain injury during post-acute intensive rehabilitation","author":"Formisano","year":"2017","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.antiviral.2019.01.014_bib101","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.3389\/fpsyg.2015.01368","article-title":"Changes in aspects of social functioning depend upon prior changes in neurodisability in people with acquired brain injury undergoing post-acute neurorehabilitation","volume":"6","author":"Fortune","year":"2015","journal-title":"Front. Psychol."},{"issue":"2","key":"10.1016\/j.antiviral.2019.01.014_bib102","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1128\/JVI.01305-07","article-title":"Establishment and maintenance of the innate antiviral response to West Nile Virus involves both RIG-I and MDA5 signaling through IPS-1","volume":"82","author":"Fredericksen","year":"2008","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.antiviral.2019.01.014_bib103","first-page":"473","article-title":"Characteristics of long-term persisting strains of tick-borne encephalitis virus in different forms of the chronic process in animals","volume":"27","author":"Frolova","year":"1982","journal-title":"Vopr. Virusol."},{"issue":"4","key":"10.1016\/j.antiviral.2019.01.014_bib104","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1089\/vim.2011.0017","article-title":"T-cell clones expressing different T-cell receptors accumulate in the brains of dying and surviving mice after peripheral infection with far eastern strain of tick-borne encephalitis virus","volume":"24","author":"Fujii","year":"2011","journal-title":"Viral Immunol."},{"issue":"1","key":"10.1016\/j.antiviral.2019.01.014_bib105","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/s41467-018-02882-0","article-title":"Structure of tick-borne encephalitis virus and its neutralization by a monoclonal antibody","volume":"9","author":"F\u00fczik","year":"2018","journal-title":"Nat. Commun."},{"issue":"Suppl. 1","key":"10.1016\/j.antiviral.2019.01.014_bib106","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s12028-017-0455-y","volume":"27","author":"Gaieski","year":"2017","journal-title":"Neurocrit Care"},{"issue":"9","key":"10.1016\/j.antiviral.2019.01.014_bib107","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1080\/14760584.2017.1358620","article-title":"Systematic literature review comparing rapid 3-dose administration of the GSK tick-borne encephalitis vaccine with other primary immunization schedules","volume":"16","author":"Galgani","year":"2017","journal-title":"Expert Rev. Vaccines"},{"issue":"6","key":"10.1016\/j.antiviral.2019.01.014_bib108","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/jnen\/64.6.506","article-title":"Visualization of Central European tick-borne encephalitis infection in fatal human cases","volume":"64","author":"Gelpi","year":"2005","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"4","key":"10.1016\/j.antiviral.2019.01.014_bib109","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1080\/13550280600848746","article-title":"Inflammatory response in human tick-borne encephalitis: analysis of postmortem brain tissue","volume":"12","author":"Gelpi","year":"2006","journal-title":"J. Neurovirol."},{"issue":"15","key":"10.1016\/j.antiviral.2019.01.014_bib110","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/S0264-410X(96)00081-3","article-title":"Tick-borne encephalitis: development of a paediatric vaccine. A controlled, randomized, double-blind and multicentre study","volume":"14","author":"Girgsdies","year":"1996","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.antiviral.2019.01.014_bib111","first-page":"49","article-title":"Results of the clinical trials of the vaccine against tick-borne encephalitis EnceVir","volume":"5","author":"Gorbunov","year":"2002","journal-title":"Epidemiology and Vaccinal Prevention"},{"key":"10.1016\/j.antiviral.2019.01.014_bib112","first-page":"57","article-title":"Report of the results of field clinical trials of a new concentrated inactivated vaccine against tick-borne encephalitis EnceVir","volume":"5","author":"Gorbunov","year":"2002","journal-title":"Epidemiologiya Infektsionnye Bolezni"},{"issue":"Pt 6","key":"10.1016\/j.antiviral.2019.01.014_bib113","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1099\/0022-1317-70-6-1605","article-title":"Antibody-dependent enhancement of yellow fever and Japanese encephalitis virus neurovirulence","volume":"70","author":"Gould","year":"1989","journal-title":"J. Gen. Virol."},{"issue":"Pt 3","key":"10.1016\/j.antiviral.2019.01.014_bib114","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1099\/0022-1317-67-3-591","article-title":"Neutralizing (54K) and non-neutralizing (54K and 48K) monoclonal antibodies against structural and non-structural yellow fever virus proteins confer immunity in mice","volume":"67","author":"Gould","year":"1986","journal-title":"J. Gen. Virol."},{"issue":"1","key":"10.1016\/j.antiviral.2019.01.014_bib115","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.virol.2006.09.015","article-title":"Genetic characterization of tick-borne flaviviruses: new insights into evolution, pathogenetic determinants and taxonomy","volume":"361","author":"Grard","year":"2007","journal-title":"Virology"},{"issue":"1\u20132","key":"10.1016\/j.antiviral.2019.01.014_bib116","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000149880","article-title":"Sheep milk-borne epidemic of tick-borne encephalitis in Slovakia","volume":"5","author":"Gres\u00edkov\u00e1","year":"1975","journal-title":"Intervirology"},{"issue":"46","key":"10.1016\/j.antiviral.2019.01.014_bib117","doi-asserted-by":"crossref","first-page":"7396","DOI":"10.1016\/j.vaccine.2010.09.003","article-title":"Tick-borne encephalitis after vaccination: vaccine failure or misdiagnosis","volume":"28","author":"Grgic-Vitek","year":"2010","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.antiviral.2019.01.014_bib118","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1128\/JVI.77.1.25-36.2003","article-title":"Characterization of a siberian virus isolated from a patient with progressive chronic tick-borne encephalitis","volume":"77","author":"Gritsun","year":"2003","journal-title":"J. Virol."},{"issue":"1\u20132","key":"10.1016\/j.antiviral.2019.01.014_bib119","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0166-3542(02)00206-1","article-title":"Tick-borne encephalitis","volume":"57","author":"Gritsun","year":"2003","journal-title":"Antivir. Res."},{"issue":"1","key":"10.1016\/j.antiviral.2019.01.014_bib120","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0928-0197(97)00273-0","article-title":"Intrathecal IgM, IgA and IgG antibody response in tick-borne encephalitis. Long-term follow-up related to clinical course and outcome","volume":"8","author":"G\u00fcnther","year":"1997","journal-title":"Clin. Diagn. Virol."},{"issue":"10","key":"10.1016\/j.antiviral.2019.01.014_bib121","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1007\/BF01962369","article-title":"Two-year survey of the incidence of Lyme borreliosis and tick-borne encephalitis in a high-risk population in Sweden","volume":"11","author":"Gustafson","year":"1992","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"5","key":"10.1016\/j.antiviral.2019.01.014_bib122","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3109\/00365549309008548","article-title":"Clinical manifestations and antibody prevalence of Lyme borreliosis and tick-borne encephalitis in Sweden: a study in five endemic areas close to Stockholm","volume":"25","author":"Gustafson","year":"1993","journal-title":"Scand. J. Infect. Dis."},{"issue":"4","key":"10.1016\/j.antiviral.2019.01.014_bib123","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002032","article-title":"Processing of genome 5' termini as a strategy of negative-strand RNA viruses to avoid RIG-I-dependent interferon induction","volume":"3","author":"Habjan","year":"2008","journal-title":"PLoS One"},{"issue":"Suppl. 1","key":"10.1016\/j.antiviral.2019.01.014_bib124","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/S0264-410X(02)00811-3","article-title":"Tick-borne encephalitis--pathogenesis, clinical course and long-term follow-up","volume":"21","author":"Haglund","year":"2003","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.antiviral.2019.01.014_bib125","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3109\/00365549609027160","article-title":"A 10-year follow-up study of tick-borne encephalitis in the stockholm area and a review of the literature: need for a vaccination strategy","volume":"28","author":"Haglund","year":"1996","journal-title":"Scand. J. Infect. Dis."},{"issue":"25","key":"10.1016\/j.antiviral.2019.01.014_bib126","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1016\/j.vaccine.2005.01.085","article-title":"Insufficient protection for healthy elderly adults by tetanus and TBE vaccines","volume":"23","author":"Hainz","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2019.01.014_bib127","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1099\/jgv.0.000991","article-title":"Rigid amphipathic fusion inhibitors demonstrate antiviral activity against African swine fever virus","volume":"99","author":"Hakobyan","year":"2018","journal-title":"J. Gen. Virol."},{"issue":"3","key":"10.1016\/j.antiviral.2019.01.014_bib128","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0264-410X(92)90003-3","article-title":"A randomized phase II study of a new tick-borne encephalitis vaccine using three different doses and two immunization regimens","volume":"10","author":"Harabacz","year":"1992","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.antiviral.2019.01.014_bib129","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006643","article-title":"A novel mechanism of antibody-mediated enhancement of flavivirus infection","volume":"13","author":"Haslwanter","year":"2017","journal-title":"PLoS Pathog."},{"issue":"4","key":"10.1016\/j.antiviral.2019.01.014_bib130","doi-asserted-by":"crossref","first-page":"E184","DOI":"10.3390\/v10040184","article-title":"Arbidol (umifenovir): a broad-spectrum antiviral drug that inhibits medically important arthropod-borne flaviviruses","volume":"10","author":"Haviernik","year":"2018","journal-title":"Viruses"},{"issue":"32","key":"10.1016\/j.antiviral.2019.01.014_bib131","doi-asserted-by":"crossref","first-page":"4774","DOI":"10.1016\/S0264-410X(01)00218-3","article-title":"Evaluation of European tick-borne encephalitis virus vaccine against recent Siberian and far-eastern subtype strains","volume":"19","author":"Hayasaka","year":"2001","journal-title":"Vaccine"},{"issue":"43","key":"10.1016\/j.antiviral.2019.01.014_bib132","doi-asserted-by":"crossref","first-page":"7559","DOI":"10.1016\/j.vaccine.2007.08.024","article-title":"Field effectiveness of vaccination against tick-borne encephalitis","volume":"25","author":"Heinz","year":"2007","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.antiviral.2019.01.014_bib133","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1002\/hep.24542","article-title":"The antiviral protein viperin inhibits hepatitis C virus replication via interaction with nonstructural protein 5A","volume":"54","author":"Helbig","year":"2011","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.antiviral.2019.01.014_bib134","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.vaccine.2015.12.029","article-title":"Tick-borne encephalitis (TBE) vaccine to medically immunosuppressed patients with rheumatoid arthritis: a prospective, open-label, multi-centre study","volume":"34","author":"Hertzell","year":"2016","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.antiviral.2019.01.014_bib135","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3390\/v5020605","article-title":"Carbohydrate-related inhibitors of dengue virus entry","volume":"5","author":"Hidari","year":"2013","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.antiviral.2019.01.014_bib136","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/infdis\/165.4.631","article-title":"Effect of high-dose dexamethasone on the outcome of acute encephalitis due to Japanese encephalitis virus","volume":"165","author":"Hoke","year":"1992","journal-title":"J. Infect. Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.antiviral.2019.01.014_bib137","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/S0264-410X(02)00819-8","article-title":"Diagnosis of tick-borne encephalitis","volume":"21","author":"Holzmann","year":"2003","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.antiviral.2019.01.014_bib138","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/(SICI)1096-9071(199601)48:1<102::AID-JMV16>3.0.CO;2-I","article-title":"Correlation between ELISA, hemagglutination inhibition, and neutralization tests after vaccination against tick-borne encephalitis","volume":"48","author":"Holzmann","year":"1996","journal-title":"J. Med. Virol."},{"issue":"10","key":"10.1016\/j.antiviral.2019.01.014_bib139","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.3201\/eid1510.090743","article-title":"Tick-borne encephalitis from eating goat cheese in a mountain region of Austria","volume":"15","author":"Holzmann","year":"2009","journal-title":"Emerg. Infect. Dis."},{"issue":"5","key":"10.1016\/j.antiviral.2019.01.014_bib140","doi-asserted-by":"crossref","first-page":"806","DOI":"10.3201\/eid1905.121442","article-title":"Tick-borne encephalitis associated with consumption of raw goat milk, Slovenia, 2012","volume":"19","author":"Hudopisk","year":"2013","journal-title":"Emerg. Infect. Dis."},{"issue":"4","key":"10.1016\/j.antiviral.2019.01.014_bib141","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.vaccine.2008.10.087","article-title":"Vaccine-induced enhancement of viral infections","volume":"27","author":"Huisman","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2019.01.014_bib142","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1099\/0022-1317-79-10-2381","article-title":"The antiviral compound ribavirin modulates the T helper (Th)1\/Th2 subset balance in hepatitis B and C virus-specific immune responses","volume":"79","author":"Hultgren","year":"1998","journal-title":"J. Gen. Virol."},{"issue":"2","key":"10.1016\/j.antiviral.2019.01.014_bib143","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0168-1702(96)01325-1","article-title":"Characterization of Langat virus antigenic determinants defined by monoclonal antibodies to E, NS1 and preM and identification of a protective, non-neutralizing preM-specific monoclonal antibody","volume":"43","author":"Iacono-Connors","year":"1996","journal-title":"Virus Res."},{"issue":"3","key":"10.1016\/j.antiviral.2019.01.014_bib144","first-page":"425","article-title":"Experience in the study of a live vaccine made from the TP-21 strain of Malayan Langat virus","volume":"39","author":"Il'enko","year":"1968","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.antiviral.2019.01.014_bib145","first-page":"126","article-title":"The possibility of preparing a live vaccine against tick-borne encephalitis from Malay langat virus TP-21","volume":"65","author":"Il'enko","year":"1989","journal-title":"Tr. Inst. Im. Pastera"},{"issue":"7","key":"10.1016\/j.antiviral.2019.01.014_bib146","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1517\/14712590903066711","article-title":"Serological response to tick-borne encephalitis (TBE) vaccination in the elderly--results from an observational study","volume":"9","author":"Jilkova","year":"2009","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.antiviral.2019.01.014_bib147","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nrd4010","article-title":"Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases","volume":"12","author":"Jordheim","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.antiviral.2019.01.014_bib148","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1146\/annurev-immunol-032712-100001","article-title":"Control of human viral infections by natural killer cells","volume":"31","author":"Jost","year":"2013","journal-title":"Annu. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.antiviral.2019.01.014_bib149","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/155005949302400203","article-title":"Spectral EEG parameters in patients with tick-borne encephalitis: a follow-up study","volume":"24","author":"Juh\u00e1sz","year":"1993","journal-title":"Clin. Electroencephalogr."},{"issue":"2","key":"10.1016\/j.antiviral.2019.01.014_bib150","first-page":"97","article-title":"Experimental contributions to active immunization of mice against the Spring-Summer (tick-borne) encephalitis by means of preparations of live and killed virus","volume":"56","author":"Kagan","year":"1939","journal-title":"Arch. Sci. Biol."},{"key":"10.1016\/j.antiviral.2019.01.014_bib151","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1093\/brain\/122.11.2067","article-title":"The clinical and epidemiological profile of tick-borne encephalitis in southern Germany 1994-1998: a prospective study of 656 patients","volume":"122","author":"Kaiser","year":"1999","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.antiviral.2019.01.014_bib152","first-page":"561","article-title":"Tick-borne encephalitis","volume":"22","author":"Kaiser","year":"2008","journal-title":"Infect. Dis. Clin."},{"issue":"8","key":"10.1016\/j.antiviral.2019.01.014_bib153","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1007\/s00115-011-3254-2","article-title":"Langzeitprognose bei prim\u00e4r myelitischer Manifestation der FSME","volume":"82","author":"Kaiser","year":"2011","journal-title":"Nervenarzt"},{"issue":"11\u201312","key":"10.1016\/j.antiviral.2019.01.014_bib154","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s10354-012-0105-0","article-title":"Tick-borne encephalitis: clinical findings and prognosis in adults","volume":"162","author":"Kaiser","year":"2012","journal-title":"Wien Med. Wochenschr."},{"issue":"5","key":"10.1016\/j.antiviral.2019.01.014_bib155","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1128\/AAC.01186-09","article-title":"Antiviral properties, metabolism, and pharmacokinetics of a novel azolo-1,2,4-triazine-derived inhibitor of influenza A and B virus replication","volume":"54","author":"Karpenko","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2019.01.014_bib156","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1186\/1471-2334-14-321","article-title":"How to approach and treat viral infections in ICU patients","volume":"14","author":"Kelesidis","year":"2014","journal-title":"BMC Infect. Dis."},{"issue":"3","key":"10.1016\/j.antiviral.2019.01.014_bib157","first-page":"316","article-title":"Concentrated purified vaccine against tick-borne encephalitis. An immunological evaluation in experiments on mice","volume":"27","author":"Khotlube\u012d","year":"1982","journal-title":"Vopr. Virusol."},{"key":"10.1016\/j.antiviral.2019.01.014_bib158","doi-asserted-by":"crossref","first-page":"106","DOI":"10.2174\/187152308784533195","article-title":"Antiviral activity of jodantipyrin: an anti-inflammatory oral therapeutic with interferon-inducing properties","volume":"7","author":"Khudoley","year":"2008","journal-title":"Anti-Inflammatory Anti-Allergy Agents Med. Chem."},{"issue":"4","key":"10.1016\/j.antiviral.2019.01.014_bib159","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/infdis\/jiq082","article-title":"A functional Toll-like receptor 3 gene (TLR3) may be a risk factor for tick-borne encephalitis virus (TBEV) infection","volume":"203","author":"Kindberg","year":"2011","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.antiviral.2019.01.014_bib160","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s15010-006-6614-2","article-title":"Delayed humoral immunity in a patient with severe tick-borne encephalitis after complete active vaccination","volume":"35","author":"Kleiter","year":"2007","journal-title":"Infection"},{"issue":"8988","key":"10.1016\/j.antiviral.2019.01.014_bib161","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(95)92527-9","article-title":"Tickborne encephalitis despite specific immunoglobulin prophylaxis","volume":"346","author":"Kluger","year":"1995","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.antiviral.2019.01.014_bib162","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s12028-016-0272-8","article-title":"Neuroglucopenia and metabolic distress in two patients with viral meningoencephalitis: a microdialysis study","volume":"25","author":"Kofler","year":"2016","journal-title":"Neurocritical Care"},{"issue":"4","key":"10.1016\/j.antiviral.2019.01.014_bib163","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/BF00145300","article-title":"Family outbreak of alimentary tick-borne encephalitis in Slovakia associated with a natural focus of infection","volume":"12","author":"Kohl","year":"1996","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.antiviral.2019.01.014_bib164","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3389\/fnhum.2014.00377","article-title":"Harnessing the power of neuroplasticity for intervention","volume":"8","author":"Kolb","year":"2014","journal-title":"Front. Hum. Neurosci."},{"issue":"28","key":"10.1016\/j.antiviral.2019.01.014_bib165","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1016\/j.vaccine.2017.03.059","article-title":"Seropersistence of TBE virus antibodies 10 years after first booster vaccination and response to a second booster vaccination with FSME-IMMUN 0.5mL in adults","volume":"35","author":"Konior","year":"2017","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.antiviral.2019.01.014_bib166","first-page":"218","article-title":"Interaction of tick\/borne encephalitis virus with mouse peritoneal macrophages. The effect of antiviral antibody and lectin","volume":"35","author":"Kopeck\u00fd","year":"1991","journal-title":"Acta Virol."},{"issue":"22","key":"10.1016\/j.antiviral.2019.01.014_bib167","first-page":"18","article-title":"Selenium concentration and status of antioxidant system in patients with tick-borne encephalitis in the Russian Far East","author":"Kovalskii","year":"2013","journal-title":"Dalnevostochny Zhurnal Infektsionnoy Patologii"},{"issue":"4","key":"10.1016\/j.antiviral.2019.01.014_bib168","doi-asserted-by":"crossref","first-page":"53","DOI":"10.29413\/ABS.2018-3.4.9","article-title":"Characteristics of the Baikal subtype of tick-borne encephalitis virus circulating in Eastern Siberia","volume":"3","author":"Kozlova","year":"2018","journal-title":"Acta Biomedica Scientifica"},{"issue":"2","key":"10.1016\/j.antiviral.2019.01.014_bib169","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.virol.2009.12.012","article-title":"GAG-binding variants of tick-borne encephalitis virus","volume":"398","author":"Kozlovskaya","year":"2010","journal-title":"Virology"},{"issue":"8","key":"10.1016\/j.antiviral.2019.01.014_bib170","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1002\/slct.201703052","article-title":"Selective inhibition of Enterovirus A species members' reproduction by furano[2,3-d]pyrimidine nucleosides revealed by antiviral activity profiling against (+)ssRNA viruses","volume":"3","author":"Kozlovskaya","year":"2018","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.antiviral.2019.01.014_bib171","first-page":"21","article-title":"EnceVir vaccine: development and implementation in practice","volume":"2","author":"Krasilnikov","year":"2004","journal-title":"Biopreparations"},{"issue":"4","key":"10.1016\/j.antiviral.2019.01.014_bib172","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00431-014-2401-8","article-title":"Clinical course and sequelae for tick-borne encephalitis among children in South Moravia (Czech Republic)","volume":"174","author":"Krbkova","year":"2015","journal-title":"Eur. J. Pediatr."},{"issue":"4","key":"10.1016\/j.antiviral.2019.01.014_bib173","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1128\/jvi.71.4.2921-2927.1997","article-title":"Pre- and postexposure protection by passive immunoglobulin but no enhancement of infection with a flavivirus in a mouse model","volume":"71","author":"Kreil","year":"1997","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.antiviral.2019.01.014_bib174","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1128\/JVI.72.4.3076-3081.1998","article-title":"Neutralizing antibodies protect against lethal flavivirus challenge but allow for the development of active humoral immunity to a nonstructural virus protein","volume":"72","author":"Kreil","year":"1998","journal-title":"J. Virol."},{"issue":"11\u201312","key":"10.1016\/j.antiviral.2019.01.014_bib175","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0264-410X(98)80102-3","article-title":"Vaccination against tick-borne encephalitis virus, a flavivirus, prevents disease but not infection, although viremia is undetectable","volume":"16","author":"Kreil","year":"1998","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.antiviral.2019.01.014_bib176","first-page":"98","article-title":"Alimentary transmission of tick-borne encephalitis in the Czech Republic (1997-2008)","volume":"58","author":"Kriz","year":"2009","journal-title":"Epidemiol. Mikrobiol. Imunol."},{"issue":"1","key":"10.1016\/j.antiviral.2019.01.014_bib177","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0042-6822(02)00097-1","article-title":"Role of heparan sulfate for attachment of Tick-Borne encephalitis virus","volume":"308","author":"Kroschewski","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2019.01.014_bib178","first-page":"86","article-title":"Antiviral activity of combined medication Zostera asiatica-derived rosmarinic acid against tick-borne encephalitis pathogen","volume":"3","author":"Kryilova","year":"2009","journal-title":"Pacific Med J"},{"issue":"3","key":"10.1016\/j.antiviral.2019.01.014_bib179","first-page":"139","article-title":"Antiviral activity of various drugs with different mechanisms of action in patients with experimental tick-borne encephalitis","volume":"61","author":"Krylova","year":"2016","journal-title":"Vopr. Virusol."},{"issue":"7\u20138","key":"10.1016\/j.antiviral.2019.01.014_bib180","first-page":"17","article-title":"In vitro activity of luromarin against tick-borne encephalitis virus","volume":"55","author":"Krylova","year":"2010","journal-title":"Antibiot. Khimioter."},{"issue":"11\u201312","key":"10.1016\/j.antiviral.2019.01.014_bib181","first-page":"7","article-title":"Comparative study of antiviral activity of luteolin and 7,3'-disulfate luteolin","volume":"56","author":"Krylova","year":"2011","journal-title":"Antibiot. Khimioter."},{"issue":"11\u201312","key":"10.1016\/j.antiviral.2019.01.014_bib182","first-page":"13","article-title":"Investigation of luromarin efficacy on mice with experimental tick-borne encephalitis","volume":"56","author":"Krylova","year":"2011","journal-title":"Antibiot. Khimioter."},{"issue":"5","key":"10.1016\/j.antiviral.2019.01.014_bib183","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1089\/vim.2014.0083","article-title":"Molecular mechanisms of interaction between human immune cells and far eastern tick-borne encephalitis virus strains","volume":"28","author":"Krylova","year":"2015","journal-title":"Viral Immunol."},{"issue":"1","key":"10.1016\/j.antiviral.2019.01.014_bib184","first-page":"113","article-title":"Salivary gland extracts of partially fed Dermacentor reticulatus ticks decrease natural killer cell activity in vitro","volume":"82","author":"Kubes","year":"1994","journal-title":"Immunology"},{"issue":"Suppl. 1","key":"10.1016\/j.antiviral.2019.01.014_bib185","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1016\/S0264-410X(02)00813-7","article-title":"TBE vaccination and the Austrian experience","volume":"21","author":"Kunz","year":"2003","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.antiviral.2019.01.014_bib186","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ttbdis.2015.04.005","article-title":"Tick-borne encephalitis as a notifiable disease--Status quo and the way forward. Report of the 17th annual meeting of the International Scientific Working Group on Tick-Borne Encephalitis (ISW-TBE)","volume":"6","author":"Kunze","year":"2015","journal-title":"Ticks Tick Borne Dis"},{"issue":"1","key":"10.1016\/j.antiviral.2019.01.014_bib187","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1128\/jvi.52.1.223-230.1984","article-title":"Lysis of dengue virus-infected cells by natural cell-mediated cytotoxicity and antibody-dependent cell-mediated cytotoxicity","volume":"52","author":"Kurane","year":"1984","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.01.014_bib188","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12974-016-0487-9","article-title":"Type I Interferon response in olfactory bulb, the site of tick-borne flavivirus accumulation, is primarily regulated by IPS-1","volume":"13","author":"Kurhade","year":"2016","journal-title":"J. Neuroinflammation"},{"issue":"2","key":"10.1016\/j.antiviral.2019.01.014_bib189","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1365-2915.1993.tb00674.x","article-title":"Enhancement of tick-borne encephalitis virus transmission by tick salivary gland extracts","volume":"7","author":"Labuda","year":"1993","journal-title":"Med. Vet. Entomol."},{"issue":"2","key":"10.1016\/j.antiviral.2019.01.014_bib190","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1006\/viro.1996.0261","article-title":"Importance of localized skin infection in tick-borne encephalitis virus transmission","volume":"219","author":"Labuda","year":"1996","journal-title":"Virology"},{"issue":"5","key":"10.1016\/j.antiviral.2019.01.014_bib191","first-page":"31","article-title":"Modern aspects of the prevention of tick-borne encephalitis","volume":"52","author":"Lashkevitch","year":"2007","journal-title":"Vopr. Virusol."},{"key":"10.1016\/j.antiviral.2019.01.014_bib192","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.antiviral.2010.05.003","article-title":"Biochemical characterization of the inhibition of the dengue virus RNA polymerase by beta-D-2 '-ethynyl-7-deaza-adenosine triphosphate","volume":"87","author":"Latour","year":"2010","journal-title":"Antivir. Res."},{"issue":"4","key":"10.1016\/j.antiviral.2019.01.014_bib193","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0154143","article-title":"Predictors, Neuroimaging Characteristics and Long-Term Outcome of Severe European Tick-Borne Encephalitis: a Prospective Cohort Study. Klein RS, editor","volume":"11","author":"Lenhard","year":"2016","journal-title":"PLoS One"},{"issue":"21","key":"10.1016\/j.antiviral.2019.01.014_bib194","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1016\/j.vaccine.2009.02.069","article-title":"Characterization of neutralizing antibodies to Far Eastern of tick-borne encephalitis virus subtype and the antibody avidity for four tick-borne encephalitis vaccines in human","volume":"27","author":"Leonova","year":"2009","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.antiviral.2019.01.014_bib195","first-page":"33","article-title":"Functional activity of specific antibodies in patients vaccinated against tick-borne encephalitis in relation to different virus strains","volume":"55","author":"Leonova","year":"2010","journal-title":"Vopr. Virusol."},{"issue":"6","key":"10.1016\/j.antiviral.2019.01.014_bib196","first-page":"260","article-title":"Antigenemia in people infected with tick-borne encephalitis virus","volume":"41","author":"Leonova","year":"1996","journal-title":"Vopr. Virusol."},{"issue":"1","key":"10.1016\/j.antiviral.2019.01.014_bib197","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.virol.2013.04.029","article-title":"Comprehensive assessment of the genetics and virulence of tick-borne encephalitis virus strains isolated from patients with inapparent and clinical forms of the infection in the Russian Far East","volume":"443","author":"Leonova","year":"2013","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.antiviral.2019.01.014_bib198","first-page":"41","article-title":"An experience of using Panavir in therapy of tick-borne encephalitis","volume":"5","author":"Lepekhin","year":"2007","journal-title":"Infektsionnye Bolezni"},{"issue":"4","key":"10.1016\/j.antiviral.2019.01.014_bib199","first-page":"55","article-title":"Assessment of effectiveness of iodantipyrine preventive use in treatment of Russian tick-borne encephalitis","volume":"111","author":"Lepekhin","year":"2012","journal-title":"Sibirsky Meditsinsky Zhurnal"},{"issue":"4","key":"10.1016\/j.antiviral.2019.01.014_bib200","doi-asserted-by":"crossref","first-page":"82","DOI":"10.21518\/2079-701X-2016-4-82-87","article-title":"New approaches to emergency prevention and treatment of viral infections by the example of tick-borne encephalitis and influenza","author":"Lepekhin","year":"2016","journal-title":"Meditsinsky Sovet"},{"key":"10.1016\/j.antiviral.2019.01.014_bib201","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1128\/JVI.79.3.1943-1947.2005","article-title":"The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of inosine monophosphate dehydrogenase","volume":"79","author":"Leyssen","year":"2005","journal-title":"J. Virol."},{"issue":"10","key":"10.1016\/j.antiviral.2019.01.014_bib202","doi-asserted-by":"crossref","first-page":"5602","DOI":"10.1128\/JVI.00143-15","article-title":"Viral infection of the central nervous system and neuroinflammation precede blood-brain barrier disruption during Japanese encephalitis virus infection","volume":"89","author":"Li","year":"2015","journal-title":"J. Virol."},{"issue":"9627","key":"10.1016\/j.antiviral.2019.01.014_bib203","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0140-6736(08)60800-4","article-title":"Tick-borne encephalitis","volume":"371","author":"Lindquist","year":"2008","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.antiviral.2019.01.014_bib204","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s12974-016-0748-7","article-title":"Fast type I interferon response protects astrocytes from flavivirus infection and virus-induced cytopathic effects","volume":"13","author":"Lindqvist","year":"2016","journal-title":"J. Neuroinflammation"},{"issue":"6","key":"10.1016\/j.antiviral.2019.01.014_bib205","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1093\/infdis\/jix040","article-title":"A cluster of fatal tick-borne encephalitis virus infection in organ transplant setting","volume":"215","author":"Lipowski","year":"2017","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.antiviral.2019.01.014_bib206","first-page":"26","article-title":"Preclinical and clinical studies of the efficacy of panavir in therapy for tick-borne encephalitis","volume":"54","author":"Litvin","year":"2009","journal-title":"Vopr. Virusol."},{"key":"10.1016\/j.antiviral.2019.01.014_bib207","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.antiviral.2016.03.013","article-title":"In vitro antiviral activity of adenosine analog NITD008 against tick-borne flaviviruses","volume":"130","author":"Lo","year":"2016","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.01.014_bib208","doi-asserted-by":"crossref","first-page":"43395","DOI":"10.1038\/srep43395","article-title":"GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses","volume":"7","author":"Lo","year":"2017","journal-title":"Sci Rep-UK"},{"key":"10.1016\/j.antiviral.2019.01.014_bib209","series-title":"Human Viral Diseases","author":"Lobzin","year":"2015"},{"issue":"24","key":"10.1016\/j.antiviral.2019.01.014_bib210","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.1016\/j.vaccine.2006.03.061","article-title":"Safety and immunogenicity of the modified adult tick-borne encephalitis vaccine FSME-IMMUN: results of two large phase 3 clinical studies","volume":"24","author":"Loew-Baselli","year":"2006","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.antiviral.2019.01.014_bib211","doi-asserted-by":"crossref","first-page":"551","DOI":"10.4161\/hv.5.8.8571","article-title":"Seropersistence of tick-borne encephalitis antibodies, safety and booster response to FSME-IMMUN 0.5 ml in adults aged 18-67 years","volume":"5","author":"Loew-Baselli","year":"2009","journal-title":"Hum Vaccin"},{"issue":"43","key":"10.1016\/j.antiviral.2019.01.014_bib212","doi-asserted-by":"crossref","first-page":"7307","DOI":"10.1016\/j.vaccine.2011.07.089","article-title":"Prevention of tick-borne encephalitis by FSME-IMMUN vaccines: review of a clinical development programme","volume":"29","author":"Loew-Baselli","year":"2011","journal-title":"Vaccine"},{"issue":"1\u20132","key":"10.1016\/j.antiviral.2019.01.014_bib213","first-page":"3","article-title":"Investigation of Triazavirin antiviral activity against tick-borne encephalitis pathogen in cell culture","volume":"59","author":"Loginova","year":"2014","journal-title":"Antibiot. Khimioter."},{"issue":"5\u20136","key":"10.1016\/j.antiviral.2019.01.014_bib214","first-page":"8","article-title":"Investigation of prophylactic efficacy of triazavirin against experimental forest-spring encephalitis on albino mice","volume":"60","author":"Loginova","year":"2015","journal-title":"Antibiot. Khimioter."},{"issue":"1","key":"10.1016\/j.antiviral.2019.01.014_bib215","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1128\/JVI.01080-07","article-title":"Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity","volume":"82","author":"Loo","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.01.014_bib216","first-page":"9","article-title":"Experience of tick-borne encephalitis vaccine use in the Leningrad military region","volume":"22","author":"Loshko","year":"2004","journal-title":"Biopreparations"},{"key":"10.1016\/j.antiviral.2019.01.014_bib217","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3201\/eid1103.040776","article-title":"Concomitant tickborne encephalitis and human granulocytic ehrlichiosis","volume":"11","author":"Lotric-Furlan","year":"2005","journal-title":"Emerg. Infect. Dis."},{"issue":"2","key":"10.1016\/j.antiviral.2019.01.014_bib218","first-page":"142","article-title":"Tick-borne encephalitis in patients vaccinated against this disease","volume":"282","author":"Lotric-Furlan","year":"2017"},{"issue":"1","key":"10.1016\/j.antiviral.2019.01.014_bib219","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.chom.2015.06.007","article-title":"Flavivirus antagonism of type I interferon signaling reveals prolidase as a regulator of IFNAR1 surface expression","volume":"18","author":"Lubick","year":"2015","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.antiviral.2019.01.014_bib389","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/00365513.2015.1084040","article-title":"Tick-borne encephalitis \u2013 lipid peroxidation and its consequences","volume":"76","author":"\u0141uczaj","year":"2016","journal-title":"Scand. J. Clin. Lab. Investig."},{"issue":"2","key":"10.1016\/j.antiviral.2019.01.014_bib220","first-page":"51","article-title":"[Epidemiologic monitoring of tick-borne encephalitis in rimov in southern bohemia]","volume":"52","author":"Lun\u00e1ckov\u00e1","year":"2003","journal-title":"Epidemiol. Mikrobiol. Imunol."},{"key":"10.1016\/j.antiviral.2019.01.014_bib221","first-page":"420","article-title":"Dynamics of serological indices of immunity in animals immunized with vaccines against tick-borne encephalitis","volume":"29","author":"Lvov","year":"1963","journal-title":"Vopr. Virusol."},{"issue":"3","key":"10.1016\/j.antiviral.2019.01.014_bib222","doi-asserted-by":"crossref","first-page":"135","DOI":"10.18821\/0507-4088-2016-61-3-135-139","article-title":"Vaccines based on the Far-Eastern and European strains induce the neutralizing antibodies against all known tick-borne encephalitis virus subtypes","volume":"61","author":"Maikova","year":"2016","journal-title":"Vopr. Virusol."},{"issue":"2","key":"10.1016\/j.antiviral.2019.01.014_bib223","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/jmv.25316","article-title":"Ability of inactivated vaccines based on far-eastern tick-borne encephalitis virus strains to induce humoral immune response in originally seropositive and seronegative recipients","volume":"91","author":"Maikova","year":"2019","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2019.01.014_bib224","first-page":"89","article-title":"Protective effects of fucoidan derived from brown algae Laminaria japonica under experimental tick-borne encephalitis","volume":"3","author":"Makarenkova","year":"2009","journal-title":"Pacific Med J"},{"key":"10.1016\/j.antiviral.2019.01.014_bib225","first-page":"44","article-title":"Antiviral effect of brown algae-derived sulphated polysaccharides in case of experimental tick-borne encephalitis: tying structure and function","volume":"1","author":"Makarenkova","year":"2012","journal-title":"Pacific Med J"},{"issue":"1","key":"10.1016\/j.antiviral.2019.01.014_bib226","doi-asserted-by":"crossref","first-page":"5627","DOI":"10.1128\/JVI.75.12.5627-5637.2001","article-title":"Adaptation of Tick-Borne encephalitis virus to BHK-21 cells results in the formation of multiple heparan sulfate binding sites in the envelope protein and attenuation in vivo","volume":"75","author":"Mandl","year":"2001","journal-title":"J. Virol."},{"issue":"12","key":"10.1016\/j.antiviral.2019.01.014_bib227","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1038\/nbt1363","article-title":"The growth and potential of human antiviral monoclonal antibody therapeutics","volume":"25","author":"Marasco","year":"2007","journal-title":"Nat. Biotechnol."},{"issue":"4","key":"10.1016\/j.antiviral.2019.01.014_bib228","first-page":"321","article-title":"Study of the virulence of tick-borne encephalitis virus. VI. Intracerebral infection of monkeys with clones experimentally attenuated virus","volume":"11","author":"Mayer","year":"1967","journal-title":"Acta Virol."},{"issue":"3","key":"10.1016\/j.antiviral.2019.01.014_bib229","first-page":"229","article-title":"A live vaccine against tick-born encephalitis: integrated studies. III. Response of man to a single dose of the E5 \"14\" clone (Langat virus)","volume":"19","author":"Mayer","year":"1975","journal-title":"Acta Virol."},{"key":"10.1016\/j.antiviral.2019.01.014_bib230","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-017-0009-5","article-title":"Cross-neutralisation of viruses of the tick-borne encephalitis complex following tick-borne encephalitis vaccination and\/or infection","author":"McAuley","year":"2017","journal-title":"NPJ Vaccines"},{"issue":"Suppl. 4","key":"10.1016\/j.antiviral.2019.01.014_bib231","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1528-1167.2012.03615.x","article-title":"Seizures and encephalitis: clinical features, management, and potential pathophysiologic mechanisms","volume":"53","author":"Michael","year":"2012","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.antiviral.2019.01.014_bib232","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1086\/342059","article-title":"Tickborne encephalitis in an area of high endemicity in Lithuania: disease severity and long\u2010term prognosis","volume":"35","author":"Mickien\u0117","year":"2002","journal-title":"Clin. Infect. Dis."},{"issue":"9","key":"10.1016\/j.antiviral.2019.01.014_bib233","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106798","article-title":"Polymorphisms in chemokine receptor 5 and Toll-like receptor 3 genes are risk factors for clinical tick-borne encephalitis in the Lithuanian population","volume":"9","author":"Mickien\u0117","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2019.01.014_bib234","doi-asserted-by":"crossref","first-page":"49164","DOI":"10.1074\/jbc.M305041200","article-title":"Characterization of resistance to non-obligate chain-terminating ribonucleoside analogs that inhibit hepatitis C virus replication in vitro","volume":"278","author":"Migliaccio","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.antiviral.2019.01.014_bib235","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.virusres.2011.11.020","article-title":"Formation of membrane-defined compartments by tick-borne encephalitis virus contributes to the early delay in interferon signaling","volume":"163","author":"Miorin","year":"2012","journal-title":"Virus Res."},{"issue":"4","key":"10.1016\/j.antiviral.2019.01.014_bib236","first-page":"269","article-title":"[Post-encephalitic syndrome in patients with tick-borne encephalitis]","volume":"63","author":"Misi\u0107 Majerus","year":"2009","journal-title":"Acta Med. Croat."},{"issue":"10","key":"10.1016\/j.antiviral.2019.01.014_bib237","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1007\/s10096-014-2134-7","article-title":"Co-infections with Borrelia species, Anaplasma phagocytophilum and Babesia spp. in patients with tick-borne encephalitis","volume":"33","author":"Moniuszko","year":"2014","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"25","key":"10.1016\/j.antiviral.2019.01.014_bib238","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1016\/j.vaccine.2014.02.046","article-title":"Evaluation of immune response and protective effect of four vaccines against the tick-borne encephalitis virus","volume":"32","author":"Morozova","year":"2014","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.antiviral.2019.01.014_bib239","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004539","article-title":"Co-infection of Ticks: the Rule Rather Than the Exception","volume":"10","author":"Moutailler","year":"2016","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"5167","key":"10.1016\/j.antiviral.2019.01.014_bib240","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1126\/science.8009221","article-title":"Functional role of type I and type II interferons in antiviral defense","volume":"264","author":"Muller","year":"1994","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.antiviral.2019.01.014_bib241","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1182\/blood-2012-01-407395","article-title":"HIV-1 infection of human macrophages directly induces viperin which inhibits viral production","volume":"120","author":"Nasr","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.antiviral.2019.01.014_bib248","doi-asserted-by":"crossref","DOI":"10.1093\/database\/bay139","article-title":"Enhanced taxonomy annotation of antiviral activity data from ChEMBL","author":"Nikitina","year":"2019","journal-title":"Database"},{"key":"10.1016\/j.antiviral.2019.01.014_bib242","doi-asserted-by":"crossref","first-page":"3944","DOI":"10.1128\/AAC.48.10.3944-3953.2004","article-title":"A 7-deaza-adenosine analog is a potent and selective inhibitor of hepatitis C virus replication with excellent pharmacokinetic properties","volume":"48","author":"Olsen","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"issue":"11","key":"10.1016\/j.antiviral.2019.01.014_bib243","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1093\/infdis\/jir122","article-title":"A tick-borne encephalitis virus vaccine based on the European prototype strain induces broadly reactive cross-neutralizing antibodies in humans","volume":"203","author":"Orlinger","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.01.014_bib244","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1039\/C5MD00538H","article-title":"Rigid amphipathic nucleosides suppress reproduction of the tick-borne encephalitis virus","volume":"7","author":"Orlov","year":"2016","journal-title":"Med Chem Commun"},{"issue":"5","key":"10.1016\/j.antiviral.2019.01.014_bib245","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.bmcl.2017.01.040","article-title":"New tools in nucleoside toolbox of tick-borne encephalitis virus reproduction inhibitors","volume":"27","author":"Orlov","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"6","key":"10.1016\/j.antiviral.2019.01.014_bib246","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.201700353","article-title":"Probing chemical space of tick-borne encephalitis virus reproduction inhibitors with organoselenium compounds","volume":"351","author":"Orlov","year":"2018","journal-title":"Arch. Pharm. (Weinheim)"},{"issue":"9","key":"10.1016\/j.antiviral.2019.01.014_bib247","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1021\/ml400226s","article-title":"Inhibitors of tick-borne flavivirus reproduction from structure-based virtual screening","volume":"4","author":"Osolodkin","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"issue":"3","key":"10.1016\/j.antiviral.2019.01.014_bib249","doi-asserted-by":"crossref","first-page":"238","DOI":"10.4161\/viru.2.3.16162","article-title":"Hiding from intracellular pattern recognition receptors, a passive strategy of flavivirus immune evasion","volume":"2","author":"Overby","year":"2011","journal-title":"Virulence"},{"issue":"17","key":"10.1016\/j.antiviral.2019.01.014_bib250","doi-asserted-by":"crossref","first-page":"8470","DOI":"10.1128\/JVI.00176-10","article-title":"Tick-borne encephalitis virus delays interferon induction and hides its double-stranded RNA in intracellular membrane vesicles","volume":"84","author":"Overby","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.01.014_bib251","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.virol.2017.04.012","article-title":"Tick-borne encephalitis virus infects human brain microvascular endothelial cells without compromising blood-brain barrier integrity","volume":"507","author":"Palus","year":"2017","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2019.01.014_bib252","article-title":"Viperin restricts Zika virus and tick-borne encephalitis virus replication by targeting NS3 for proteasomal degradation","author":"Panayiotou","year":"2018","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.antiviral.2019.01.014_bib253","first-page":"309","article-title":"Diagnosis and treatment of tick-borne diseases recommendations of the polish society of epidemiology and infectious diseases","volume":"69","author":"Pancewicz","year":"2015","journal-title":"Przegl. Epidemiol."},{"key":"10.1016\/j.antiviral.2019.01.014_bib254","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD010247.pub2","article-title":"Antiepileptic drugs for the primary and secondary prevention of seizures in viral encephalitis","volume":"10","author":"Pandey","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.antiviral.2019.01.014_bib255","series-title":"Tick-borne Encephalitis. Leningrad","first-page":"282","author":"Panov","year":"1956"},{"issue":"50","key":"10.1016\/j.antiviral.2019.01.014_bib256","doi-asserted-by":"crossref","first-page":"7027","DOI":"10.1016\/j.vaccine.2009.09.068","article-title":"Booster vaccinations against tick-borne encephalitis: 6 years follow-up indicates long-term protection","volume":"27","author":"Paulke-Korinek","year":"2009","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.antiviral.2019.01.014_bib257","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.vaccine.2012.12.075","article-title":"Factors associated with seroimmunity against tick borne encephalitis virus 10 years after booster vaccination","volume":"31","author":"Paulke-Korinek","year":"2013","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.antiviral.2019.01.014_bib258","first-page":"50","article-title":"A cultured concentrated inactivated vaccine against tick-borne encephalitis studied during the immunization of children and adolescents","author":"Pavlova","year":"1999","journal-title":"Zh. Mikrobiol. Epidemiol. Immunobiol."},{"issue":"7\u20138","key":"10.1016\/j.antiviral.2019.01.014_bib259","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/S0264-410X(02)00593-5","article-title":"Tolerability of modified tick-borne encephalitis vaccine FSME-IMMUN \"NEW\" in children: results of post-marketing surveillance","volume":"21","author":"Pavlova","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2019.01.014_bib260","first-page":"24","article-title":"Characteristics of national inactivated vaccines against TBE for children and adolescents immunization","volume":"1","author":"Pavlova","year":"2003","journal-title":"BIOpreparation"},{"issue":"3","key":"10.1016\/j.antiviral.2019.01.014_bib261","first-page":"92","article-title":"[Use of Anaferon for treatment and prophylaxis of tick-borne encephalitis]","author":"Pavlova","year":"2009","journal-title":"Poliklinika"},{"issue":"1","key":"10.1016\/j.antiviral.2019.01.014_bib262","first-page":"53","article-title":"[Efficiency of use of immunoglobulin preparations for the postexposure prevention of tick-borne encephalitis in Russia (a review of semi-centennial experience)]","author":"Pen'evskaia","year":"2010","journal-title":"Med Parazitol (Mosk)."},{"issue":"1","key":"10.1016\/j.antiviral.2019.01.014_bib263","first-page":"39","article-title":"Etiotropic preparations for post-exposure tick-borne encephalitis prevention: perspective development and problems of epidemiological effectiveness evaluation","author":"Penievskaya","year":"2010","journal-title":"Epidemiologiya I Vaktsinoprofilaktika"},{"issue":"3","key":"10.1016\/j.antiviral.2019.01.014_bib264","first-page":"309","article-title":"Use of cross-absorbed sera in neutralization tests with viral titration by the cytopathogenic effect","author":"Pervikov","year":"1975","journal-title":"Vopr. Virusol."},{"issue":"Pt 8","key":"10.1016\/j.antiviral.2019.01.014_bib265","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1099\/0022-1317-66-8-1831","article-title":"Antibody-dependent enhancement of tick-borne encephalitis virus infectivity","volume":"66","author":"Phillpotts","year":"1985","journal-title":"J. Gen. Virol."},{"issue":"3","key":"10.1016\/j.antiviral.2019.01.014_bib266","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.immuni.2007.08.012","article-title":"Innate recognition of viruses","volume":"27","author":"Pichlmair","year":"2007","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.antiviral.2019.01.014_bib267","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.vaccine.2008.11.082","article-title":"Long-term persistence of tick-borne encephalitis antibodies in adults 5 years after booster vaccination with Encepur Adults","volume":"27","author":"Plentz","year":"2009","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.antiviral.2019.01.014_bib268","first-page":"7","article-title":"[Monitoring of tick-borne encephalitis virus populations and etiological structure of morbidity over 60 years]","volume":"50","author":"Pogodina","year":"2005","journal-title":"Vopr. Virusol."},{"key":"10.1016\/j.antiviral.2019.01.014_bib269","series-title":"Reminiscences on M. P. Chumakov","first-page":"21","article-title":"Everything started from tick-borne encephalitis","author":"Pogodina","year":"2009"},{"key":"10.1016\/j.antiviral.2019.01.014_bib270","series-title":"Chronic Tick-borne Encephalitis","author":"Pogodina","year":"1986"},{"issue":"4","key":"10.1016\/j.antiviral.2019.01.014_bib271","first-page":"20","article-title":"[The Siberian and Far-Eastern subtypes of tick-borne encephalitis virus registered in Russia's Asian regions: genetic and antigen characteristics of the strains]","volume":"49","author":"Pogodina","year":"2004","journal-title":"Vopr. Virusol."},{"issue":"6","key":"10.1016\/j.antiviral.2019.01.014_bib272","first-page":"24","article-title":"[Comparative analysis of virulence of the Siberian and Far-East subtypes of the tick-born encephalitis virus]","volume":"49","author":"Pogodina","year":"2004","journal-title":"Vopr. Virusol."},{"key":"10.1016\/j.antiviral.2019.01.014_bib273","first-page":"110","article-title":"Structure of tick-borne encephalitis populations in the Sverdlovsk region nowadays and vaccine prevention questions. Medical virology","volume":"23","author":"Pogodina","year":"2006","journal-title":"Proceedings of Chumakov Institute of poliomyelitis and viral encephalitides"},{"issue":"29","key":"10.1016\/j.antiviral.2019.01.014_bib274","doi-asserted-by":"crossref","first-page":"4680","DOI":"10.1016\/j.vaccine.2010.04.047","article-title":"Comparison of immunogenicity and safety between two paediatric TBE vaccines","volume":"28","author":"P\u00f6llabauer","year":"2010","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.antiviral.2019.01.014_bib275","first-page":"34","article-title":"Reactogenicity and antigenic activity of a chromatographic cultured purified and concentrated inactivated dried vaccine against tick-borne encephalitis","author":"Popov","year":"1985","journal-title":"Zh. Mikrobiol. Epidemiol. Immunobiol."},{"issue":"1","key":"10.1016\/j.antiviral.2019.01.014_bib276","first-page":"82","article-title":"Vaccination of human volunteers against Russian spring-summer (RSS) virus complex with attenuated Langat E5 virus","volume":"42","author":"Price","year":"1970","journal-title":"Bull. World Health Organ."},{"issue":"4","key":"10.1016\/j.antiviral.2019.01.014_bib277","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061094","article-title":"Exploring of primate models of tick-borne flaviviruses infection for evaluation of vaccines and drugs efficacy","volume":"8","author":"Pripuzova","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.antiviral.2019.01.014_bib278","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3109\/00365549509018965","article-title":"Prevalence of antibodies against tick-borne encephalitis among residents of north-eastern Poland","volume":"27","author":"Prokopowicz","year":"1995","journal-title":"Scand. J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.01.014_bib279","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejmech.2018.05.040","article-title":"3'-O-Substituted 5-(perylen-3-ylethynyl)-2'-deoxyuridines as tick-borne encephalitis virus reproduction inhibitors","volume":"155","author":"Proskurin","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.antiviral.2019.01.014_bib280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/femspd\/ftu002","article-title":"Anti-tick-borne encephalitis (TBE) virus neutralizing antibodies dynamics in natural infections versus vaccination","volume":"73","author":"Remoli","year":"2015","journal-title":"Pathog Dis"},{"issue":"21\u201322","key":"10.1016\/j.antiviral.2019.01.014_bib281","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1016\/j.vaccine.2004.01.041","article-title":"Persistence of protective immunity following vaccination against tick-borne encephalitis--longer than expected?","volume":"22","author":"Rendi-Wagner","year":"2004","journal-title":"Vaccine"},{"issue":"Suppl. 40","key":"10.1016\/j.antiviral.2019.01.014_bib282","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ijmm.2006.01.030","article-title":"Persistence of antibodies after vaccination against tick-borne encephalitis","volume":"296","author":"Rendi-Wagner","year":"2006","journal-title":"Int J Med Microbiol"},{"issue":"27","key":"10.1016\/j.antiviral.2019.01.014_bib283","doi-asserted-by":"crossref","first-page":"5097","DOI":"10.1016\/j.vaccine.2007.01.116","article-title":"Antibody persistence following booster vaccination against tick-borne encephalitis: 3-year post-booster follow-up","volume":"25","author":"Rendi-Wagner","year":"2007","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.antiviral.2019.01.014_bib284","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1054\/blre.1999.0121","article-title":"Monocyte-macrophage system as targets for immunomodulation by intravenous immunoglobulin","volume":"14","author":"Rhoades","year":"2000","journal-title":"Blood Rev."},{"issue":"6","key":"10.1016\/j.antiviral.2019.01.014_bib285","first-page":"2744","article-title":"Tick-borne flaviviruses antagonize both IRF-1 and type I IFN signaling to inhibit dendritic cell function","volume":"192","author":"Robertson","year":"2014","journal-title":"Immunol."},{"issue":"Pt 6","key":"10.1016\/j.antiviral.2019.01.014_bib286","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1099\/vir.0.040899-0","article-title":"West Nile virus-induced disruption of the blood-brain barrier in mice is characterized by the degradation of the junctional complex proteins and increase in multiple matrix metalloproteinases","volume":"93","author":"Roe","year":"2012","journal-title":"J. Gen. Virol."},{"issue":"5","key":"10.1016\/j.antiviral.2019.01.014_bib287","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1080\/09602011.2013.799076","article-title":"Post-traumatic growth, illness perceptions and coping in people with acquired brain injury","volume":"23","author":"Rogan","year":"2013","journal-title":"Neuropsychol. Rehabil."},{"key":"10.1016\/j.antiviral.2019.01.014_bib288","first-page":"115","article-title":"[Evaluation of virasole efficiency for prevention of tick-borne encephalitis in experiments in laboratory mice], Medical virology","volume":"vol. 25","author":"Rogova","year":"2008"},{"key":"10.1016\/j.antiviral.2019.01.014_bib289","first-page":"116","article-title":"Massive immunization of the Sverdlovsk region population against tick-borne encephalitis, its epidemiological, clinical and immunological efficacy. Medical virology","volume":"vol. 23","author":"Romanenko","year":"2006"},{"issue":"6","key":"10.1016\/j.antiviral.2019.01.014_bib290","first-page":"22","article-title":"Experience in implementing the mass immunization program against tick-borne encephalitis in the Sverdlovsk Region","volume":"52","author":"Romanenko","year":"2007","journal-title":"Vopr. Virusol."},{"issue":"11\u201312","key":"10.1016\/j.antiviral.2019.01.014_bib291","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s10354-012-0101-4","article-title":"Tick-borne encephalitis in children","volume":"162","author":"Rostasy","year":"2012","journal-title":"Wien Med. Wochenschr."},{"key":"10.1016\/j.antiviral.2019.01.014_bib292","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/1471-2334-13-306","article-title":"May early intervention with high dose intra-venous immunoglobulin pose a potentially successful treatment for severe cases of tick-borne encephalitis?","volume":"13","author":"Ruzek","year":"2013","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.01.014_bib293","series-title":"Neurovial Infections","first-page":"211","article-title":"Tick-borne encephalitis","author":"Ruzek","year":"2013"},{"issue":"2","key":"10.1016\/j.antiviral.2019.01.014_bib294","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.virol.2008.01.010","article-title":"Mutations in the NS2B and NS3 genes affect mouse neuroinvasiveness of a Western European field strain of tick-borne encephalitis virus","volume":"374","author":"Ruzek","year":"2008","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.antiviral.2019.01.014_bib295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2008.11.023","article-title":"CD8+ T-cells mediate immunopathology in tick-borne encephalitis","volume":"384","author":"Ruzek","year":"2009","journal-title":"Virology"},{"issue":"4","key":"10.1016\/j.antiviral.2019.01.014_bib296","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.tmaid.2010.06.004","article-title":"Tick-borne encephalitis: pathogenesis and clinical implications","volume":"8","author":"Ruzek","year":"2010","journal-title":"Trav. Med. Infect. Dis."},{"issue":"5","key":"10.1016\/j.antiviral.2019.01.014_bib297","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020472","article-title":"Breakdown of the blood-brain barrier during tick-borne encephalitis in mice is not dependent on CD8+ T-cells","volume":"6","author":"Ruzek","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.antiviral.2019.01.014_bib298","first-page":"23","article-title":"Nucleotide sequence of genes and complete amino acid sequence of tick-borne encephalitis virus strain 205","author":"Safronov","year":"1991","journal-title":"Mol Gen Mikrobiol Virusol"},{"issue":"4","key":"10.1016\/j.antiviral.2019.01.014_bib299","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jcv.2004.07.014","article-title":"The importance of tick-borne encephalitis virus RNA detection for early differential diagnosis of tick-borne encephalitis","volume":"33","author":"Saksida","year":"2005","journal-title":"J. Clin. Virol."},{"issue":"7","key":"10.1016\/j.antiviral.2019.01.014_bib300","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.3201\/eid2407.180059","article-title":"Virus RNA load in patients with tick-borne encephalitis, Slovenia","volume":"24","author":"Saksida","year":"2018","journal-title":"Emerg. Infect. Dis."},{"issue":"3","key":"10.1016\/j.antiviral.2019.01.014_bib301","first-page":"31","article-title":"Clinical and laboratory parameters when using combined therapy (immunoglobulin and interferon \u03b12v) in patients with feverish and meningeal forms of tick-borne encephalitis","author":"Salabay","year":"2012","journal-title":"Zemsky Vrach"},{"key":"10.1016\/j.antiviral.2019.01.014_bib302","doi-asserted-by":"crossref","first-page":"6394105","DOI":"10.1155\/2017\/6394105","article-title":"Improvement in quality metrics outcomes and patient and family satisfaction in a neurosciences intensive care unit after creation of a dedicated neurocritical care team","volume":"2017","author":"Sarpong","year":"2017","journal-title":"Critical Care Res. Practice"},{"issue":"4","key":"10.1016\/j.antiviral.2019.01.014_bib303","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.4049\/jimmunol.135.4.2805","article-title":"Protection against 17D yellow fever encephalitis in mice by passive transfer of monoclonal antibodies to the nonstructural glycoprotein gp48 and by active immunization with gp48","volume":"135","author":"Schlesinger","year":"1985","journal-title":"J. Immunol."},{"issue":"24","key":"10.1016\/j.antiviral.2019.01.014_bib304","doi-asserted-by":"crossref","first-page":"12549","DOI":"10.1128\/JVI.01440-10","article-title":"Peptide inhibitors of flavivirus entry derived from the E protein stem","volume":"84","author":"Schmidt","year":"2010","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.antiviral.2019.01.014_bib305","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1177\/08830738050200060601","article-title":"Neurologic, neuropsychologic, and electroencephalographic findings after European tick-borne encephalitis in children","volume":"20","author":"Schmolck","year":"2005","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.antiviral.2019.01.014_bib306","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev-immunol-032713-120231","article-title":"Interferon-stimulated genes: a complex web of host defenses","volume":"32","author":"Schneider","year":"2014","journal-title":"Annu. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.antiviral.2019.01.014_bib307","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4161\/hv.3.2.3747","article-title":"Tick-born encephalitis (TBE) vaccination in children: advantage of the rapid immunization schedule (i.e., days 0, 7, 21)","volume":"3","author":"Schoendorf","year":"2007","journal-title":"Hum Vaccin"},{"issue":"6","key":"10.1016\/j.antiviral.2019.01.014_bib308","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.coviro.2011.10.008","article-title":"Interferon-stimulated genes and their antiviral effector functions","volume":"1","author":"Schoggins","year":"2011","journal-title":"Curr Opin Virol"},{"issue":"8","key":"10.1016\/j.antiviral.2019.01.014_bib309","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.vaccine.2006.10.028","article-title":"Tick-borne encephalitis (TBE) vaccination: applying the most suitable vaccination schedule","volume":"25","author":"Schondorf","year":"2007","journal-title":"Vaccine"},{"issue":"20","key":"10.1016\/j.antiviral.2019.01.014_bib310","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1016\/j.vaccine.2014.01.072","article-title":"Irregular tick-borne encephalitis vaccination schedules: the effect of a single catch-up vaccination with FSME-IMMUN. A prospective non-interventional study","volume":"32","author":"Schosser","year":"2014","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.antiviral.2019.01.014_bib311","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1039\/C4OB02649G","article-title":"Synthesis and assessment of 4-aminotetrahydroquinazoline derivatives as tick-borne encephalitis virus reproduction inhibitors","volume":"13","author":"Sedenkova","year":"2015","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.antiviral.2019.01.014_bib312","series-title":"Tick-borne Encephalitis. International Symposium Baden\/Vienna 19th\u201320th October 1979","first-page":"45","article-title":"Immunopathology and immunotherapy of tick-borne encephalitis","author":"Semenov","year":"1981"},{"key":"10.1016\/j.antiviral.2019.01.014_bib313","first-page":"162","article-title":"Evaluation of the field experience with formalin-inactivated mouse brain vaccine of Russian spring-summer encephalitis virus against Kyasanur Forest disease","volume":"50","author":"Shah","year":"1962","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.antiviral.2019.01.014_bib314","series-title":"Chronic Forms of Tick-borne Encephalitis","author":"Shapoval","year":"1976"},{"key":"10.1016\/j.antiviral.2019.01.014_bib315","first-page":"133","article-title":"Study of the distant consequences of immunizing people with a live vaccine against tick-borne encephalitis","volume":"65","author":"Shapoval","year":"1989","journal-title":"Tr. Inst. Im. Pastera"},{"key":"10.1016\/j.antiviral.2019.01.014_bib316","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.3389\/fmicb.2016.02172","article-title":"Lethal experimental tick-borne encephalitis infection: influence of two strains with similar virulence on the immune response","volume":"7","author":"Shevtsova","year":"2017","journal-title":"Front. Microbiol."},{"issue":"2","key":"10.1016\/j.antiviral.2019.01.014_bib317","first-page":"9","article-title":"Vernal (Verno-aestival) endemic tick-borne encephalitis","volume":"56","author":"Silber","year":"1939","journal-title":"Arch. Sci. Biol."},{"issue":"24","key":"10.1016\/j.antiviral.2019.01.014_bib318","doi-asserted-by":"crossref","first-page":"12060","DOI":"10.1128\/JVI.01650-06","article-title":"CD4+ T-cell responses are required for clearance of West Nile virus from the central nervous system","volume":"80","author":"Sitati","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.01.014_bib319","first-page":"23","article-title":"Contemporary possibilities of extra nonspecific prophylaxis of tick born encephalitis in children","volume":"7","author":"Skripchenko","year":"2007","journal-title":"Pediatricheskaya Farmakologiya"},{"issue":"Suppl. 1","key":"10.1016\/j.antiviral.2019.01.014_bib320","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1016\/S1090-3798(15)30376-7","article-title":"P63 \u2013 2804: chemoprophylaxis of tick-borne encephalitis in children","volume":"19","author":"Skripchenko","year":"2015","journal-title":"Eur. J. Paediatr. Neurol."},{"issue":"12","key":"10.1016\/j.antiviral.2019.01.014_bib321","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144988","article-title":"The Burden of Tick-Borne Encephalitis in Disability-Adjusted Life Years (DALYs) for Slovenia","volume":"10","author":"\u0160mit","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2019.01.014_bib322","first-page":"3","article-title":"Experimental materials on active immunization against tick-borne (spring-summer) encephalitis","volume":"4","author":"Smorodintseff","year":"1941","journal-title":"Zh. Mikrobiol. Epidemiol. Immunobiol."},{"key":"10.1016\/j.antiviral.2019.01.014_bib323","series-title":"Tick-borne Encephalitis and Prevention Tick-borne Encephalitis and its Vaccine Prophylaxis. AMS USSR, Leningrad, \u201cMedicine\u201d","author":"Smorodintsev","year":"1986"},{"issue":"6","key":"10.1016\/j.antiviral.2019.01.014_bib324","first-page":"31","article-title":"[Morphogenesis of tick-borne encephalitis virus in the brain of mice infected with its persistent strains]","volume":"55","author":"Sobolev","year":"2010","journal-title":"Vopr. Virusol."},{"issue":"3","key":"10.1016\/j.antiviral.2019.01.014_bib325","first-page":"25","article-title":"A comparative efficacy and safety of using antiviral drugs in therapy of patients with influenza","volume":"15","author":"Sologub","year":"2017","journal-title":"Infectious Diseases"},{"key":"10.1016\/j.antiviral.2019.01.014_bib326","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jinf.2011.11.014","article-title":"Management of suspected viral encephalitis in adults \u2013 association of British neurologists and British infection association national guidelines","volume":"64","author":"Solomon","year":"2012","journal-title":"J. Infect."},{"key":"10.1016\/j.antiviral.2019.01.014_bib327","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.antiviral.2017.11.018","article-title":"Antivirals acting on viral envelopes via biophysical mechanisms of action","volume":"149","author":"Speerstra","year":"2018","journal-title":"Antivir. Res."},{"issue":"4","key":"10.1016\/j.antiviral.2019.01.014_bib328","first-page":"1","article-title":"Epidemiology of tick-borne encephalitis (TBE) in international travellers to Western\/Central Europe and conclusions on vaccination recommendations","volume":"23","author":"Steffen","year":"2016","journal-title":"J. Trav. Med."},{"issue":"1","key":"10.1016\/j.antiviral.2019.01.014_bib400","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ttbdis.2018.08.003","article-title":"Tick-borne encephalitis (TBE) in children in Europe: Epidemiology, clinical outcome and comparison of vaccination recommendations","volume":"10","author":"Steffen","year":"2019","journal-title":"Ticks Tick Borne Dis"},{"key":"10.1016\/j.antiviral.2019.01.014_bib329","first-page":"17","article-title":"Dendritic cells: translating innate to adaptive immunity","volume":"311","author":"Steinman","year":"2006","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"50","key":"10.1016\/j.antiviral.2019.01.014_bib330","doi-asserted-by":"crossref","first-page":"7021","DOI":"10.1016\/j.vaccine.2009.09.069","article-title":"Characteristics of antibody responses in tick-borne encephalitis vaccination breakthroughs","volume":"27","author":"Stiasny","year":"2009","journal-title":"Vaccine"},{"issue":"9\u201310","key":"10.1016\/j.antiviral.2019.01.014_bib331","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1134\/S1995078012050138","article-title":"Physicochemical properties of high-molecular-weight plant polysaccharide of hexose glycoside class (Panavir) with antiviral activity","volume":"7","author":"Stovbun","year":"2012","journal-title":"Nanotecnologies in Russia"},{"issue":"2","key":"10.1016\/j.antiviral.2019.01.014_bib332","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s40265-013-0007-5","article-title":"Acute viral infections of the central nervous system in immunocompetent adults: diagnosis and management","volume":"73","author":"Studahl","year":"2013","journal-title":"Drugs"},{"key":"10.1016\/j.antiviral.2019.01.014_bib333","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1097\/01.CCM.0000146132.29042.4C","article-title":"Length of stay and mortality in neurocritically ill patients: impact of a specialized neurocritical care team","volume":"32","author":"Suarez","year":"2004","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.antiviral.2019.01.014_bib334","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s00103-004-0837-0","article-title":"Durch Zecken uebertragene humanpathogene und bisher als apathogen geltende Mikroorganismen in Europa. Teil II:bakterien, Parasiten and Mischinfection","volume":"47","author":"Suess","year":"2004","journal-title":"Bundesgesundheitbl. Gesunsheitsforsch. Gesundheitsschutz."},{"key":"10.1016\/j.antiviral.2019.01.014_bib335","series-title":"TBE - the Book.","first-page":"85","article-title":"TBE in children","author":"Sundin","year":"2017"},{"key":"10.1016\/j.antiviral.2019.01.014_bib336","series-title":"Tick-borne Encephalitis (65th Anniversary) Vladivostok","first-page":"170","article-title":"Dynamics of specific immunity development during vaccination against tick-borne encephalitis","author":"Surova","year":"2002"},{"issue":"26","key":"10.1016\/j.antiviral.2019.01.014_bib337","doi-asserted-by":"crossref","DOI":"10.2807\/ese.13.26.18916-en","article-title":"Tick-borne encephalitis in Europe and beyond--the epidemiological situation as of 2007","volume":"13","author":"Suss","year":"2008","journal-title":"Euro Surveill."},{"issue":"9","key":"10.1016\/j.antiviral.2019.01.014_bib338","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1128\/AAC.00041-07","article-title":"Antiviral and anti-inflammatory effects of rosmarinic acid in an experimental murine model of Japanese encephalitis","volume":"51","author":"Swarup","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"issue":"22","key":"10.1016\/j.antiviral.2019.01.014_bib339","doi-asserted-by":"crossref","first-page":"11557","DOI":"10.1128\/JVI.05519-11","article-title":"The interferon-inducible gene viperin restricts West Nile virus pathogenesis","volume":"85","author":"Szretter","year":"2011","journal-title":"J. Virol."},{"issue":"10","key":"10.1016\/j.antiviral.2019.01.014_bib340","doi-asserted-by":"crossref","DOI":"10.1111\/ene.13356","article-title":"EAN consensus review on prevention, diagnosis and management of tick-borne encephalitis","volume":"24","author":"Taba","year":"2017","journal-title":"Eur. J. Neurol."},{"issue":"5","key":"10.1016\/j.antiviral.2019.01.014_bib341","first-page":"229","article-title":"Anaferon, released-active from of antibodies to IFN\u03b3, as an effective medicine for treatment and prophylaxis of a wide spectrum of infections","volume":"2","author":"Tarasov","year":"2016","journal-title":"Clin Res Trials"},{"issue":"3","key":"10.1016\/j.antiviral.2019.01.014_bib342","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.chom.2011.08.004","article-title":"TRIM79alpha, an interferon-stimulated gene product, restricts tick-borne encephalitis virus replication by degrading the viral RNA polymerase","volume":"10","author":"Taylor","year":"2011","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.antiviral.2019.01.014_bib343","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jiph.2016.04.002","article-title":"BCX4430-A broad-spectrum antiviral adenosine nucleoside analog under development for the treatment of Ebola virus disease","volume":"9","author":"Taylor","year":"2016","journal-title":"J Infect Public Heal"},{"issue":"12","key":"10.1016\/j.antiviral.2019.01.014_bib344","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1172\/JCI63120","article-title":"Viperin restricts chikungunya virus replication and pathology","volume":"122","author":"Teng","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.antiviral.2019.01.014_bib345","doi-asserted-by":"crossref","first-page":"743","DOI":"10.3201\/eid0906.030007","article-title":"Tick-borne encephalitis with hemorrhagic syndrome, Novosibirsk region, Russia, 1999","volume":"9","author":"Ternovoi","year":"2003","journal-title":"Emerg. Infect. Dis."},{"issue":"5","key":"10.1016\/j.antiviral.2019.01.014_bib346","article-title":"Retraction: novel Approach to Activity Evaluation for Release-Active Forms of Anti-Interferon-Gamma Antibodies Based on Enzyme-Linked Immunoassay","volume":"13","author":"The PLOS ONE","year":"2018","journal-title":"PLoS One"},{"issue":"Pt 4","key":"10.1016\/j.antiviral.2019.01.014_bib347","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1099\/0022-1317-79-4-689","article-title":"Immunological basis for protection in a murine model of tick-borne encephalitis by a recombinant adenovirus carrying the gene encoding the NS1 non-structural protein","volume":"79","author":"Timofeev","year":"1998","journal-title":"J. Gen. Virol."},{"issue":"2","key":"10.1016\/j.antiviral.2019.01.014_bib348","first-page":"166","article-title":"About the pathogenesis of progredient forms of tick-borne encephalitis","volume":"77","author":"Umansky","year":"1977","journal-title":"J. Neuropathol. Psychiatry"},{"issue":"2","key":"10.1016\/j.antiviral.2019.01.014_bib349","first-page":"10","article-title":"Immunotherapy of some acute and chronic neuroinfections","volume":"81","author":"Umanskyi","year":"1981","journal-title":"Zh. Nevropatol. Psikhiatr. Im. S S Korsakova"},{"issue":"6","key":"10.1016\/j.antiviral.2019.01.014_bib350","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/cmi.12241","article-title":"Viperin is an iron-sulfur protein that inhibits genome synthesis of tick-borne encephalitis virus via radical SAM domain activity","volume":"16","author":"Upadhyay","year":"2014","journal-title":"Cell Microbiol."},{"issue":"2","key":"10.1016\/j.antiviral.2019.01.014_bib351","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s10096-017-3139-9","article-title":"Diagnosing tick-borne encephalitis: a re-evaluation of notified cases","volume":"37","author":"Veje","year":"2018","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"2","key":"10.1016\/j.antiviral.2019.01.014_bib352","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.vaccine.2006.07.026","article-title":"Study of the serological response after vaccination against tick-borne encephalitis in Sweden","volume":"25","author":"Vene","year":"2007","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.antiviral.2019.01.014_bib353","first-page":"206","article-title":"Diagnosis and management of acute encephalitis: a practical approach","volume":"4","author":"Venkatesan","year":"2014","journal-title":"Neurology: Clin. Pract."},{"issue":"3","key":"10.1016\/j.antiviral.2019.01.014_bib354","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1128\/JVI.02907-13","article-title":"The rigid amphipathic fusion inhibitor dUY11 acts through photosensitization of viruses","volume":"88","author":"Vigant","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.01.014_bib355","series-title":"Tick-borne Encephalitis. International Symposium Baden\/Vienna 19th\u201320th October 1979","first-page":"76","article-title":"Pathogenetic problems arising from experiences in series of experiments with TBE in mice","author":"Vince","year":"1981"},{"issue":"6","key":"10.1016\/j.antiviral.2019.01.014_bib356","first-page":"438","article-title":"Comparative study of CNS lesions induced by tick-borne encephalitis virus in normal and x-irradiated white mice","volume":"38","author":"Vince","year":"1972","journal-title":"Pathol. Microbiol."},{"key":"10.1016\/j.antiviral.2019.01.014_bib357","article-title":"Viperin targets flavivirus virulence by inducing assembly of non-infectious capsid particles","author":"Vonderstein","year":"2017","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.antiviral.2019.01.014_bib358","first-page":"622","article-title":"Reactogenicity and immunological effectiveness of a concentrated, purified vaccine against tick-borne encephalitis","volume":"28","author":"Vorob'eva","year":"1983","journal-title":"Vopr. Virusol."},{"issue":"5","key":"10.1016\/j.antiviral.2019.01.014_bib359","first-page":"221","article-title":"Comparative study of inactivated cultured vaccines against tick-borne encephalitis manufactured in Russia and in Austria by the \"Immuno\" firm","volume":"41","author":"Vorob'eva","year":"1996","journal-title":"Vopr. Virusol."},{"issue":"2","key":"10.1016\/j.antiviral.2019.01.014_bib360","first-page":"25","article-title":"The application of preparation \u00abReaferon-ES-LIPINT\u00bb for the prevention of the Tick-borne encephalitis","author":"Vorobeva","year":"2012","journal-title":"Zemsky Vrach"},{"issue":"3","key":"10.1016\/j.antiviral.2019.01.014_bib361","first-page":"117","article-title":"New inactivated TBE vaccines","volume":"19","author":"Vorovitch","year":"2012","journal-title":"J Infectious Pathology"},{"key":"10.1016\/j.antiviral.2019.01.014_bib362","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1186\/s40064-015-1561-y","article-title":"Genetic description of a tick-borne encephalitis virus strain Sofjin with the longest history as a vaccine strain","volume":"4","author":"Vorovitch","year":"2015","journal-title":"SpringerPlus"},{"issue":"2","key":"10.1016\/j.antiviral.2019.01.014_bib363","doi-asserted-by":"crossref","first-page":"73","DOI":"10.18821\/0507-4088-2017-62-2-73-80","article-title":"Immunogenicity and safety of the adult TBE vaccine \u00abTick-E-Vac\u00bb","volume":"62","author":"Vorovitch","year":"2017","journal-title":"Vopr. Virusol."},{"issue":"9","key":"10.1016\/j.antiviral.2019.01.014_bib364","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/BF02002905","article-title":"Severe tick-borne encephalitis following passive immunization","volume":"155","author":"Waldvogel","year":"1996","journal-title":"Eur. J. Pediatr."},{"issue":"2","key":"10.1016\/j.antiviral.2019.01.014_bib365","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.chom.2007.06.009","article-title":"The interferon-inducible protein viperin inhibits influenza virus release by perturbing lipid rafts","volume":"2","author":"Wang","year":"2007","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.antiviral.2019.01.014_bib366","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nature13027","article-title":"Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430","volume":"508","author":"Warren","year":"2014","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.antiviral.2019.01.014_bib367","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1017\/S0022172400041218","article-title":"Langat virus encephalitis in mice. I. The effect of the administration of specific antiserum","volume":"66","author":"Webb","year":"1968","journal-title":"J. Hyg."},{"issue":"10","key":"10.1016\/j.antiviral.2019.01.014_bib368","doi-asserted-by":"crossref","first-page":"5059","DOI":"10.1128\/JVI.80.10.5059-5064.2006","article-title":"Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses","volume":"80","author":"Weber","year":"2006","journal-title":"J. Virol."},{"issue":"21","key":"10.1016\/j.antiviral.2019.01.014_bib369","doi-asserted-by":"crossref","first-page":"12202","DOI":"10.1128\/JVI.01215-14","article-title":"Type I interferon protects mice from fatal neurotropic infection with Langat virus by systemic and local antiviral responses","volume":"88","author":"Weber","year":"2014","journal-title":"J. Virol."},{"issue":"20","key":"10.1016\/j.antiviral.2019.01.014_bib370","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1016\/j.vaccine.2010.03.024","article-title":"Decreased antibody titers and booster responses in tick-borne encephalitis vaccinees aged 50-90 years","volume":"28","author":"Weinberger","year":"2010","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.antiviral.2019.01.014_bib371","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/s41467-017-01669-z","article-title":"Dengue virus-reactive CD8+ T cells mediate cross-protection against subsequent Zika virus challenge","volume":"8","author":"Wen","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2019.01.014_bib372","first-page":"114(","article-title":"Patient med TBE f\u00f6rb\u00e4ttrades snabbt vid behandling med kortison - evidens saknas dock f\u00f6r v\u00e4rdet av immunmodulerande terapi. [Article in Swedish]","author":"Wengse","year":"2017","journal-title":"Lakartidningen"},{"issue":"3","key":"10.1016\/j.antiviral.2019.01.014_bib373","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/j.1462-5822.2007.01076.x","article-title":"Tick-borne encephalitis virus NS5 associates with membrane protein scribble and impairs interferon-stimulated JAK-STAT signalling","volume":"10","author":"Werme","year":"2008","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.antiviral.2019.01.014_bib374","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3389\/fmicb.2013.00337","article-title":"Ticks and tick-borne pathogens at the cutaneous interface: host defenses, tick countermeasures, and a suitable environment for pathogen establishment","volume":"4","author":"Wikel","year":"2013","journal-title":"Front. Microbiol."},{"issue":"10","key":"10.1016\/j.antiviral.2019.01.014_bib375","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.vaccine.2008.12.057","article-title":"Long-term persistence of tick-borne encephalitis antibodies in children 5 years after first booster vaccination with Encepur Children","volume":"27","author":"Wittermann","year":"2009","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.antiviral.2019.01.014_bib376","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/j.vaccine.2008.10.003","article-title":"Antibody response following administration of two paediatric tick-borne encephalitis vaccines using two different vaccination schedules","volume":"27","author":"Wittermann","year":"2009","journal-title":"Vaccine"},{"issue":"15","key":"10.1016\/j.antiviral.2019.01.014_bib377","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/j.vaccine.2015.02.038","article-title":"Five year follow-up after primary vaccination against tick-borne encephalitis in children","volume":"33","author":"Wittermann","year":"2015","journal-title":"Vaccine"},{"issue":"48","key":"10.1016\/j.antiviral.2019.01.014_bib378","doi-asserted-by":"crossref","first-page":"20435","DOI":"10.1073\/pnas.0907010106","article-title":"An adenosine nucleoside inhibitor of dengue virus","volume":"106","author":"Yin","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.antiviral.2019.01.014_bib379","doi-asserted-by":"crossref","first-page":"43","DOI":"10.15374\/fz2013012","article-title":"Tick-borne encephalitis \u2013 epidemiology, pathogenesis and clinical course, prophylaxis and treatment","volume":"4","author":"Zajkowska","year":"2013","journal-title":"Forum Zaka\u017ce\u0144"},{"issue":"Suppl. 1","key":"10.1016\/j.antiviral.2019.01.014_bib380","first-page":"158","article-title":"[Encephalomeningitis caused by Listeria monocytogenes in patient infected by TBE virus--case report]","volume":"62","author":"Zajkowska","year":"2008","journal-title":"Przegl. Epidemiol."},{"issue":"4","key":"10.1016\/j.antiviral.2019.01.014_bib381","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0028-3843(14)60113-4","article-title":"Fatal outcome of tick-borne encephalitis \u2013 a case series","volume":"45","author":"Zajkowska","year":"2011","journal-title":"Neurol. Neurochir. Pol."},{"issue":"9","key":"10.1016\/j.antiviral.2019.01.014_bib382","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.3201\/eid1909.130804","article-title":"Chorea and tick-borne encephalitis, Poland","volume":"19","author":"Zajkowska","year":"2013","journal-title":"Emerg. Infect. Dis."},{"issue":"2","key":"10.1016\/j.antiviral.2019.01.014_bib383","doi-asserted-by":"crossref","first-page":"362","DOI":"10.4161\/hv.22766","article-title":"Recommendations for tick-borne encephalitis vaccination from the central european vaccination awareness group (CEVAG)","volume":"9","author":"Zavadska","year":"2013","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.antiviral.2019.01.014_bib384","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.cytogfr.2016.03.006","article-title":"Brain heterogeneity leads to differential innate immune responses and modulates pathogenesis of viral infections","volume":"30","author":"Zegenhagen","year":"2016","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.antiviral.2019.01.014_bib385","doi-asserted-by":"crossref","first-page":"210","DOI":"10.4172\/2314-7326.1000210","article-title":"Differences in IPS-1 mediated innate immune responses between neurotrophic flavivirus infection","volume":"7","author":"Zegenhagen","year":"2016","journal-title":"J. Neuroinfectious Diseases"},{"issue":"5","key":"10.1016\/j.antiviral.2019.01.014_bib386","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1586\/14760584.4.5.747","article-title":"Tick-borne encephalitis vaccines: past and present","volume":"4","author":"Zent","year":"2005","journal-title":"Expert Rev. Vaccines"},{"issue":"25\u201326","key":"10.1016\/j.antiviral.2019.01.014_bib387","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1016\/S0264-410X(03)00421-3","article-title":"Safety, immunogenicity and tolerability of a new pediatric tick-borne encephalitis (TBE) vaccine, free of protein-derived stabilizer","volume":"21","author":"Zent","year":"2003","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.antiviral.2019.01.014_bib388","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s00234-015-1568-7","article-title":"Bilateral symmetrical basal ganglia and thalamic lesions in children: an update (2015)","volume":"57","author":"Zuccoli","year":"2015","journal-title":"Neuroradiology"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354218304479?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354218304479?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:28:05Z","timestamp":1759062485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354218304479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":390,"alternative-id":["S0166354218304479"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.01.014","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tick-borne encephalitis in Europe and Russia: Review of pathogenesis, clinical features, therapy, and vaccines","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}